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Whole genome sequencing projects have expanded our understanding of 
evolution, organism development, and human disease. Now advances in second-
generation technologies are making whole genome sequencing routine even for small 
laboratories. However, advances in annotation technology have not kept pace with 
genome sequencing, and annotation has become the major bottleneck for many 
genome projects (especially those with limited bioinformatics expertise). At the same 
time, challenges associated with genomics research extend beyond merely 
annotating genomes, as annotations must be subjected to diverse downstream 
analyses, the complexities of which can confound smaller research groups. 
Additionally, with improvements in genome assembly and the wide availability of 
next generation transcriptome data (mRNA-seq), researchers have the opportunity 
to re-annotate previously published genomes, which creates new difficulties for data 
integration and management that are not well addressed by existing tools. 
In response to the challenges facing second-generation genome projects, I 
have developed the annotation pipeline MAKER2 together with accessory software 
for downstream analysis and data management. The MAKER2 annotation pipeline 
finds repeats within a genome, aligns ESTs and cDNAs, identifies sites of protein 
homology, and produces database-ready gene annotations in association with 
supporting evidence. However MAKER2 can go beyond structural annotation to 
identify and integrate functional annotations. MAKER2 also provides researchers 
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with the capability to re-annotate legacy genome datasets and to incorporate mRNA-
seq. Additionally, MAKER2 supports distributed parallelization on computer 
clusters, thus providing a scalable solution for datasets of any size. 
Annotations produced by MAKER2 can be directly loaded into many popular 
downstream annotation analysis and management tools from the Generic Model 
Organism Database Project. By using MAKER2 with these tools, research groups 
can quickly build genome annotations, perform analyses, and distribute their data to 
the wider scientific community. 
Here I describe the internal architecture of MAKER2, and document its 
computational capabilities. I also describe my work to annotate and analyze eight 
emerging model organism genomes in collaboration with their associated genome 
projects. Thus, in the course of my thesis work, I have addressed a specific need 
within the scientific community for easy-to-use annotation and analysis tools while 

















For my beautiful wife, Marlene, and my four wonderful 









TABLE OF CONTENTS 
ABSTRACT..................................................................................................................... iii 
LIST OF TABLES ........................................................................................................viii 




1 INTRODUCTION .................................................................................................. 1 
Background........................................................................................................ 1 
MAKER2, an easy-to-use annotation solution................................................. 6 
Summary of findings ......................................................................................... 9 
References.......................................................................................................... 9 
2 MAKER2: AN ANNOTATION PIPELINE AND GENOME-DATABASE 
MANAGEMENT TOOL FOR SECOND-GENERATION GENOME PROJECTS .. 13 
Abstract............................................................................................................ 14 
Background...................................................................................................... 14 
Results and discussion .................................................................................... 17 
Conclusions...................................................................................................... 32 
Methods............................................................................................................ 34 
List of abbreviations........................................................................................ 42 
Authors' contributions..................................................................................... 42 
Acknowledgements.......................................................................................... 43 
References........................................................................................................ 43 
3 THE PROOF-OF-PRINCIPLE ANNOTATION OF EIGHT EMERGING 
MODEL ORGANISM GENOMES ...................................................................... 58 
Introduction ..................................................................................................... 58 




4 EDUCATIONAL OUTREACH............................................................................ 94 
References........................................................................................................ 96 
 vii 
5 MAKER WEB ANNOTATION SERVICE: AN ONLINE PORTAL FOR 
GENOME ANNOTATION AND ANALYSIS ..................................................... 97 
Abstract............................................................................................................ 97 
Rationale.......................................................................................................... 97 
Algorithm/website design ............................................................................... 98 
Annotation of Pinus taeda BAC clones ........................................................ 103 
Conclusions.................................................................................................... 105 
Availability and requirements...................................................................... 106 
Methods.......................................................................................................... 106 
References...................................................................................................... 107 
6 ALGORITHM DESIGN ..................................................................................... 115 
Supported system architectures ................................................................... 116 
Input to MAKER2 ......................................................................................... 116 
MAKER2’s output ......................................................................................... 117 
Step-by-step overview of MAKER2 .............................................................. 117 
Algorithm stability and error handling........................................................ 127 
References...................................................................................................... 128 











LIST OF TABLES 
Table 
2.1 Gene model accuracy for gene prediction/annotation programs ........................ 49	  
2.2 Sensitivity and specificity for prediction/annotation programs ......................... 49	  
2.3 Gene model accuracy using unmatched species parameters............................. 50	  
2.4 Sensitivity and specificity using unmatched species parameters ........................ 50	  









LIST OF FIGURES 
Figure 
1.1 View of MAKER2 annotations and evidence...................................................... 12 
2.1 MAKER2 vs. ab initio predictors on second-generation genomes..................... 52 
2.2 Evaluating AED as a metric for annotation quality control.............................. 53 
2.3 AED evaluation of Homo sapiens reference annotations .................................. 54 
2.4 Re-annotation of a portion of the maize genome using MAKER2..................... 55 
2.5 MAKER2 as a management tool for existing genome annotations................... 56 
2.6 MAKER2 scales to even the largest genomes .................................................... 57 
3.1 Comparison of domain content in Oomycetes .................................................... 89 
3.2 Domain content in reference eukaryotes ............................................................ 90 
3.3 Comparison of intron/exon structure across eukaryotes ................................... 91 
3.4 Phylogenetic analysis of Schmidtea mediterranea ............................................ 92 
3.5 Genes shared by Schmidtea mediterranea with other metazoans.................... 93 
5.1 MWAS login screen............................................................................................ 109 
5.2 The MWAS job submission screen .................................................................... 110 
5.3 View of MWAS annotations in Apollo............................................................... 111 
5.4 Annotation summary statistics ......................................................................... 112 
5.5 View of MWAS functional annotation integration........................................... 113 
5.6 Association of results and analyses with gene annotations ............................ 114 
6.1 Flowchart of MAKER2’s design and operation ................................................ 130 










I’d like to thank and recognize all contributions from my advisor Mark 
Yandell, lab member Hao Hu, and former lab members Brandi Cantarel and Hadi 
Islam in developing MAKER2. I would also like to recognize our collaborator Ian 
Korf at UC Davis and his lab member Genis Parra for their contributions. Dave 
Clements at Emory University deserves special recognition for his work in 
promoting MAKER2 and maintaining MAKER2 documentation on the GMOD wiki 
page. In addition, I want to thank and recognize the involvement and contributions 
made by the many collaborators who have been integrally involved in annotation 
and analysis of the genomes processed by MAKER2: Alejandro Sánchez Alvarado 
(University of Utah), Robin Buell (Michigan State University), Weiming Li 
(Michigan State University), Allen Kovach (UC Davis), Brenda Wingfield 
(University of Pretoria, South Africa), Christopher D. Smith (San Francisco State 
University), Christopher R. Smith (Earlham College), Jürgen Gadau (Arizona State 
University), Neil Tsutsui (UC Berkeley), and Cameron Currie (University of 
Wisconsin-Madison). 
This work was supported by the NIH/NHGRI grant R01-HG004694 and 
partially supported by the NIH Genetics Training Grant T32-GM007464. An 
allocation of computer time from the Center for High Performance Computing at the 









    
CHAPTER 1 
INTRODUCTION 
MAKER2 is an automated genome annotation pipeline that identifies 
repetitive elements in a genome, aligns Expressed Sequence Tags (ESTs) and 
protein homology evidence to a genome, and synthesizes these data into database-
ready genome annotations. MAKER2 is based on the annotation pipeline 
MAKER[1]. Here I provide an introduction to the process of genome annotation, the 
rationale behind MAKER2’s development, and an explanation of important design 
considerations for the pipeline. 
Background 
While second-generation sequencing technologies are making great strides in 
bringing down sequencing costs, focus on these achievements tends to overlook the 
fact that raw DNA sequence in and of itself really isn’t that useful. Given a newly 
sequenced genome, what researchers most want to know is, “where are the genes 
and what do they do”? The process of identifying genes within a genome sequence, 
documenting their intron-exon structures with supporting evidence, and assigning 
them putative functions is referred to as genome annotation. 
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What are genome annotations? 
Annotations are essentially models describing a gene’s intron-exon structure, 
alternate splice forms, UTR locations, coding regions, etc. Gene annotations can also 
describe other features such as gene expression profiles, a gene’s molecular function, 
the biological pathway a gene is involved in, or the orthologous relationship of a gene 
to another species. Gene annotations are therefore the nuclei around which our 
electronic knowledge of a genome and an organism grows.  
The annotation process 
Because of the size of most genomes, experimental identification and 
verification of all genes and annotations within them is impossible (at least in the 
short run). Annotations are therefore the result of logical deductions based on 
evidence from EST and cDNA alignments, protein homology, and ab initio gene 
predictions. 
Eukaryotes pose a significant challenge for gene annotation because of their 
large intron-containing genes, relatively low gene densities, alternative splice forms, 
and high concentrations of transposons and repetitive elements. Finding and 
describing genes in these organisms can be difficult, and building genome 
annotations for them requires an exhaustive process in which ab initio gene 
predictions, EST and cDNA alignments, and homology to known proteins must be 
taken into consideration. Of course, managing these data on a genomewide scale 
also requires sophisticated computational methods. 
To a large degree, the first-generation of genome annotations were created 
manually (these were classic model organisms like Drosophila melanogaster, 
Caenorhabditis elegans, and Saccharomyces cerevisiae). Manual annotation is and 
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was a very complex, time-consuming endeavor, especially considering the thousands 
of genes present in the average eukaryotic organism. Despite it being so laborious, 
for the first generation of genome projects, the process of annotation was still far less 
expensive and labor intensive than genome sequencing. For this reason, 
organizations associated with early genome projects, like FlyBase[2] and Celera, 
were willing to employ hundreds of scientists as manual curators. Even today 
manual curation still remains the ‘gold-standard’[3, 4] by which to judge the quality 
of automated annotation tools. 
At the end of the annotation process, gene annotations, the evidence 
supporting those annotations, and genome features such as repeat elements are 
combined into a database in order to produce a complete model of the genome 
(including structure and features). Researchers can query the database for 
information they need to design experiments such as protein domain analyses, gene 
knock-out/knock-in type experiments, etc. The genome database also serves as a 
substrate for improving gene annotations via manual and automated review of 
experimental evidence (ESTs, protein homology, etc.). 
Automatically generated annotations are far from perfect, and manual gene 
annotation remains the ‘gold-standard’ for evaluating annotation confidence and 
quality. However, manual annotation is an expensive and time-consuming process. 
For this reason, classification and prioritization of annotations for later manual 
review is critical for the maintenance of a genome database. A classification scheme 
requires that each annotation be tagged with information describing the type of 
evidence that supports each gene model. The requirement for evidence trails, 
therefore, further complicates genome annotation. 
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The genome annotation bottleneck 
As second-generation sequencing technology has improved, annotation (not 
sequencing) has become the major bottleneck to genomics research. For example, as 
of January 2011, 463 genomes were fully sequenced yet unpublished (an ever-
growing backlog of un-annotated genomes), and over 1,600 eukaryotic genome 
projects were underway[5]. With a conservative estimate of just 10,000 genes per 
genome, these projects alone will produce over 16,000,000 new gene annotations that 
must be generated, maintained, and updated to reflect new research. With even 
more genome projects just over the horizon, it is obvious that manual curation is no 
longer feasible, and better fully-automated solutions are required. Unfortunately, 
second-generation genome projects are overwhelmingly associated with small 
research communities that often lack the bioinformatics skills necessary to 
implement their own automated annotation pipelines or easily build and maintain 
an annotation database. 
Alternative solutions for annotation  
Some research groups have taken an alternate approach to building and 
maintaining their own genome annotation pipeline by outsourcing annotations to 
major databases such as ENSEMBL[6] or VectorBase[7]. However, the number of 
un-annotated genomes far exceeds the capacity and stated purview of these 
databases. ENSEMBL, for example, has traditionally been focused on vertebrate 
genomes, and VectorBase is limited to insect vectors of human disease. Many 
research groups are also unwilling to give up control of their genome datasets to 




In recognition of the difficulties confronted by research groups trying to 
annotate their respective organism’s genome, some sequencing centers and major 
genome databases have made parts of their own in-house annotation pipelines 
available to the public. ENSEMBL, for example, provides an extensive suite of 
annotation, alignment, and data management tools[8]. However, distributing 
annotation tools is not part of the primary mission of large genome databases, and 
what is made available constitutes only a subset of their internal systems. For large 
research groups with extensive bioinformatics experience, these tools can be 
sufficient when supplemented with other in-house pipeline development. Small 
research groups with little bioinformatics experience, however, are left with few 
options when trying to build and manage gene annotations and evidence. 
The Generic Model Organism Database project 
Because of the limited availability of software for genome annotation and 
analysis, the Generic Model Organism Database project (GMOD)[9] was formed. The 
goal of GMOD is to provide open source software tools for managing genome-scale 
biological databases as well as facilitating downstream analyses. GMOD also has the 
goal of having all its software tools be interoperable via a standard file format, 
Generic Feature Format version 3 (GFF3)[10], which is used for describing genome 
features and annotations. While the GMOD suite of components contains a large 
selection of software for manipulating and analyzing annotations, they fall short of 
providing a tool that can build and combine annotations and evidence into a new 
database (at least until MAKER2 was developed). Once again leaving small research 
projects with no easy annotation solution. 
6 
 
MAKER2, an easy-to-use annotation solution 
To confront the many difficulties faces by second-generation genome projects, 
I have developed MAKER2, a genome annotation pipeline designed to be easy-to-use 
for small research groups with little bioinformatics experience. MAKER2 joined 
GMOD in 2008 and fills a “big hole” in that project (as there was no tool capable of 
producing de novo annotations in GMOD before MAKER2). The MAKER2 
annotation pipeline is based on the earlier genome annotation pipeline MAKER[1], 
but MAKER2 greatly expands on the earlier program’s capabilities and 
functionality. MAKER2 integrates existing software tools into a package that 
produces database-ready genome annotations together with associated evidence and 
quality control statistics. It identifies and masks repetitive elements in the genome, 
aligns ESTs and protein homology evidence, produces ab initio gene predictions, 
infers five and three prime UTRs, and integrates all these data to produce final gene 
annotations with quality control statistics that help prioritize genes for downstream 
review and manual curation. MAKER2 does not produce gene predictions by itself; 
rather, it integrates existing ab initio gene prediction programs like SNAP[11], 
Augustus[12], and GeneMark[13] for this purpose. However, rather than just 
accepting the raw ab initio gene predictions produced by these algorithms, MAKER2 
uses evidence alignments to provide ‘hints’ to the prediction programs as to the 
location of probable introns, exons, and coding regions. MAKER2 also actively 
modifies the resulting predictions to include features like UTR that can be inferred 
from EST alignments. In this way, MAKER2 guides the behavior of ab initio 
prediction programs using experimental evidence to produce improved models. The 
final output of MAKER2 is in GFF3 format, which is the common file format used by 
GMOD tools. Because of the common format, MAKER2’s output can be directly 
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loaded into GMOD tools like Apollo[14] (an annotation viewing and curation tool), 
Chado (a database schema)[15], GBrowse[16] (an online annotation viewing and 
distribution tool), and Galaxy[17] (an analysis pipeline). MAKER2’s output can thus 
be easily utilized for downstream curation, data distribution, and experimental 
analysis. 
Design considerations for MAKER2  
Creating an easy-to-use annotation pipeline forces one to confront several 
software design challenges. First, the pipeline should be simple to install, configure, 
and run; this means using it should require only basic bioinformatics skills and it 
must be runnable with the types of computational resources that would be 
encountered in an average laboratory. However, because of the wide variation in 
genome size and content for different organisms, the pipeline must also be scalable – 
able to handle datasets both large and small by taking full of advantage of all 
computational resources that may be available to it. MAKER2 meets these 
requirements by being compatible with UNIX-like operating systems such as Linux 
and Mac OS X (machines found in most laboratories) and by integrating support for 
Message Passing Interface (MPI), which is a distributed parallelization protocol 
used in computer clusters. This means MAKER2 can either run on a laptop 
computer, or if needed, expand its analyses on a computer cluster to thousands of 
CPUs and process datasets of virtually any size. 
An easy-to-use pipeline must perform basic tasks of evidence alignment and 
interpretation. Therefore not only is MAKER2 required to identify repetitive 
elements, produce ab initio gene predictions, and align ESTs and proteins to the 
genome, but the pipeline must also integrate those data to synthesize feature-rich 
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gene annotations that include three and five prime UTRs, alternative splice forms, 
and an evidence trail that can be used for downstream analysis and quality control. 
MAKER2 achieves this by leveraging existing tools such as RepeatMasker[18] (for 
repeat identification), BLAST[19] (for evidence alignment), Exonerate[20] (to polish 
alignments), and SNAP[11] (a gene-predictor). These are all programs that have 
been highly optimized to do a specific task very well. By integrating and interpreting 
their outputs, MAKER2 takes advantage of these tools’ many combined years of 
research and development, to produce gene annotations that could not have been 
generated by any of the programs individually. Figure 1.1 shows how evidence 
alignments from programs used by MAKER2 correlate with the resulting genome 
annotations, thus both suggesting and confirming each aspect of the final gene 
model. 
Another design consideration for an easy-to-use annotation pipeline is 
trainability. Because every genome is different, an annotation pipeline must be 
easily trained, thus maximizing the accuracy of gene models produced for each new 
organism. MAKER2 takes advantage of aligned evidence to identify organism 
specific patterns in intron/exon structures that can then be conveyed to ab initio 
gene-predictors like SNAP and Augustus. These programs then produce improved 
evidence-based gene models that can become the basis for further training of ab 
initio gene-predictors. In this way, MAKER2 can be trained on new organisms via a 
bootstrap-like procedure. 
The final essential feature of an easy-to-use annotation pipeline is that its 
output must rigorously describe all aspects of the gene annotations and their 
associated evidence in a machine-readable fashion. The output format must also be 
compatible with other commonly used tools and applications, and users must be able 
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to view and edit individual contigs with only minimal computational resources. 
These tasks have been simplified for us by the Generic Model Organism Database 
project (GMOD), which provides a suite of tools for viewing, curating, distributing, 
and analyzing genome annotations via a single common file format, GFF3. Thus by 
producing genome annotations in GFF3 format, MAKER2 gives its users access to 
extensive software resources that are already freely available.  
Summary of findings 
MAKER2 is a simple solution to the genome annotation needs of projects 
associated with smaller research groups. It provides an efficient mechanism to 
produce annotations using evidence derived from ESTs, protein alignments, and ab 
initio gene predictions. MAKER2’s output also facilitates downstream analysis via 
integration with GMOD tools. 
While MAKER2, by design, is meant to facilitate the generation and analysis 
of genome annotations, it is not meant to be an exhaustive algorithm. The pipeline 
does not identify noncoding RNA genes, nor does it provide comprehensive solutions 
to every problem in genome annotation. MAKER2 does, however, produce database-
ready protein-coding gene annotations that serve as the substrate for further 
analysis and experimentation, thus helping to jump-start research in newly 
sequence organisms. 
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Figure 1.1. View of MAKER2 annotations and evidence. 
MAKER2 produced genome annotations and aligned experimental evidence are 
displayed in the Apollo annotation curation tool. The pattern of experimental 
alignments (upper dark panel) correlates with the intron/exon structure of the 
genome annotations (lower blue panel), thus both suggesting and supporting 



















    
CHAPTER 2 
MAKER2: AN ANNOTATION PIPELINE AND 
GENOME-DATABASE MANAGEMENT 
TOOL FOR SECOND-GENERATION 
GENOME PROJECTS 
From “MAKER2: an annotation pipeline and genome-database management 
tool for second-generation genome projects,” by Carson Holt and Mark Yandell, 
Submitted to Genome Biology. Copyright 2011 Carson Holt and Mark Yandell. This 
is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited. 
My contributions to this study include conceiving and carrying out the 





Second-generation sequencing technologies are precipitating major shifts 
with regards to what kinds of genomes are being sequenced and how they are 
annotated. While the first generation of genome projects focused on well-studied 
model organisms, today’s genome projects are focused on new, often exotic, 
organisms whose genomes are largely terra incognita. This complicates their 
annotation, because unlike first-generation projects, there are no pre-existing gene-
models with which to train gene-finders. Today's second-generation genome projects 
are also faced with challenges that extend beyond de novo annotation. 
Improvements in genome assembly and the wide availability of mRNA-seq data are 
creating opportunities to re-annotate previously published genomes and to update 
their legacy annotations. This, in turn, creates data management problems not 
encountered by the first wave of genome projects. A better understanding of the 
impact of these issues on today's genome projects is essential for successful 
annotation and on-going annotation management. Here, we provide in-depth 
analyses of these challenges and explain how MAKER2 solves them. 
Background 
Second-generation sequencing technologies are creating new opportunities as 
well as new challenges for genomics research. While first-generation genome 
projects focused primarily on established model organisms such as Drosophila 
melanogaster[1], Caenorhabditis elegans[2], and Mus musculus[3], falling 
sequencing costs allow second-generation genome projects to focus on less well-
understood, often exotic and phylogenetically isolated organisms. These genomes 
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present researchers with formable challenges, as their novel contents can make 
them difficult substrates for annotation. The large volumes of data produced by 
second-generation sequencing technologies also create difficulties for data 
management not encountered by first-generation projects. Together, these two 
factors can spell disaster for the small research communities in charge of many 
second-generation genome projects, as they generally lack the bioinformatics 
experience and resources necessary to manually revise, curate, and manage 
annotations. 
A major challenge facing many second-generation projects is the exotic 
nature of their organism’s genomes. The first-generation of genome projects 
benefited greatly from large bodies of pre-existing knowledge regarding their 
organisms’ genomes. For D. melanogaster, C. elegans, and H. sapiens[4, 5], for 
example, hundreds of gene models already existed before the genomes were 
sequenced. These pre-existing gene models were critical for annotation and analysis, 
because they allowed researchers to train and optimize gene prediction tools for each 
genome. They also provided a standard by which to judge the accuracy of 
annotations. Second-generation projects rarely have access to such information. This 
severely limits their ability to train ab initio gene-finders, the result being low-
quality gene predictions. The lack of pre-existing gene models also leaves many 
second-generation projects with no objective standards with which to gauge 
annotation accuracy. Quality control is thus a significant issue for these projects. 
Data management is another. 
New techniques such as high-throughput transcriptome sequencing (mRNA-
seq) have great potential to improve annotation quality, but they produce enormous 
amounts of data; likewise, the existence of legacy annotations for a large number of 
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both first and second-generation genomes is also creating data management 
challenges. How exactly does one go about updating a genome’s worth of annotations 
to take into account new mRNA-seq data? How does one know that the annotations 
are improved? 
Demographic and economic issues further exacerbate these difficulties. The 
small research communities driving second-generation genome projects often lack 
significant bioinformatics experience. They also often lack the economic resources 
needed to manage and distribute the results of the genome annotation projects. 
Thus, it is essential that the output of an annotation pipeline be easily converted 
into a genome database — and there is a great need for automated means to manage 
them. 
MAKER2 builds upon MAKER[6], an easy-to-use genome annotation pipeline 
that has seen wide adoption[7-19]. MAKER2 provides straightforward solutions to 
the problems facing today’s second-generation genome projects. Here, we 
demonstrate its ability to overcome handicaps resulting from a lack of pre-existing 
gene models with which to train gene-predictors for use on novel genomes; its ability 
to use mRNA-seq data to improve annotation quality; and its ability to update legacy 
annotations (significantly improving their quality).  
Throughout these analyses, we measure MAKER2’s performance using an 
integrated annotation quality control measure, Annotation Edit Distance (AED)[20], 
developed by the Sequence Ontology project[21]. Thus, MAKER2 is not only an 
improved annotation engine; it is also an annotation management tool. We show 
that MAKER2 can both evaluate the global quality of genome annotations, and 
identify and prioritize individually problematic annotations for manual review; 
these are functionalities offered by no other annotation tool. 
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Results and discussion 
Genome annotation in classic model organism genomes 
The performance of de novo annotation tools such as HMM based ab initio 
gene-predictors and evidence based annotation pipelines have previously been 
explored in competitions such as EGASP[22] and NGASP[23], which looked at gene 
prediction and annotation accuracy in the human and C. elegans genomes, 
respectively. From these competitions, the metrics sensitivity, specificity, and 
accuracy have emerged as the standard methods for evaluating the quality of gene 
predictions[24]. Both measurements require a set of reference gene models that are 
assumed to be correct; gene predictions are then compared to the reference model to 
generate sensitivity, specificity, and accuracy values (see Methods). 
Using these metrics, we compared the performance of MAKER2 to the ab 
initio gene prediction programs SNAP[25], GeneMark[26], and Augustus[27, 28]. We 
used the organism specific parameter files that come bundled with each of these 
algorithms to produce ab initio gene predictions for D. melanogaster chromosome 
3R, C. elegans chromosome V, and Arabidopsis thaliana[29] chromosome 4. For 
comparison, we then produced evidence-based genome annotations by running the 
same three algorithms (SNAP, GeneMark, and Augustus) inside of the MAKER2 
genome annotation pipeline. Sensitivity, specificity, and accuracy values were then 
calculated against the respective reference genome using the program Eval[30] 
(Table 2.1 and Table 2.2).  
As seen in Table 2.1, the base pair and exon level accuracy values for ab initio 
predictions produced by SNAP, Augustus, and GeneMark are very similar, generally 
within a few percentage points of each other. In C. elegans, for example, the 
difference between low and high base pair level accuracies is only 3.19% (85.10% for 
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SNAP vs. 88.29% for Augustus). The corresponding MAKER2 annotations have 
similar accuracies relative to the ab initio gene predictions, and more often than not, 
they are slightly improved over the ab initio gene predictions (but the difference is 
small). In C. elegans, for example, base pair level accuracies in MAKER2 range from 
86.29% to 88.48% which is comparable to the 85.10% to 88.29% range for the ab 
initio gene predictions. This is not the first time that this trend has been 
observed[23] — given large enough training sets, ab initio gene prediction programs 
can match or even outperform annotation pipelines. Augustus, for example, achieved 
an exon-level accuracy in C. elegans of 74.62%, compared to MAKER2’s 68.60% 
(Table 2.1).  
The relative similarity of accuracy measurements for ab initio prediction 
methods vs. MAKER2 suggests that MAKER2 is performing on par with these ab 
initio tools (but not greatly improving accuracy). However, as we show below, such 
comparisons can be quite misleading from a second-generation genome perspective. 
The key to understanding why is grasping that Table 2.1 reports the performance of 
the ab initio predictors after they have been trained using each genome’s existing 
annotations — datasets containing tens of thousands of often hand-curated gene 
models. Data such as those shown in Table 2.1 thus represent the upper bounds for 
performance of the ab initio prediction algorithms. As we demonstrate below, when 
training sets decrease in quality and/or size, the accuracy of ab initio tools drops 
dramatically; MAKER2’s accuracy, however, remains high. This feature of MAKER2 
makes it especially useful for second-generation genome projects as these projects 
generally lack large enough training datasets for ab initio predictors to achieve 
accuracies comparable to those shown in Table 2.1. 
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Genome annotation using unmatched species parameters 
To better understand how these algorithms perform using limited or poor 
quality training data, we repeated our analysis shown in Table 2.1 using the same 
portions of D. melanogaster chromosome 3R, C. elegans chromosome V, and A. 
thaliana chromosome 4; but this time we ran the gene-predictors using the wrong 
species file for each organism. D. melanogaster and C. elegans were analyzed using 
the species file from A. thaliana, and A. thaliana was analyzed using the species file 
from C. elegans. Each ab initio gene prediction program was then run inside of the 
MAKER2 annotation pipeline using the same incorrect species file for comparison. 
As expected, the accuracy of the ab initio prediction algorithms is reduced 
substantially (Table 2.3 and Table 2.4). The reduction in accuracy is most notable at 
the exon level where all accuracies were approximately half of what was seen in the 
previous analysis. However, when each ab initio prediction program was run inside 
of MAKER2, accuracies dramatically improved for every organism at both the base 
pair and exon levels. The degree of improvement was most notable for SNAP, where 
exon level accuracies for A. thaliana increased from 18.58% to 60.11% (an over 
three-fold increase in accuracy). In fact, SNAP’s performance inside of MAKER2 
using the incorrect species file seems to match or even beat levels of performance 
experienced by all three ab initio gene-predictors when run using the correct species 
files. For example in D. melanogaster, when using the incorrect SNAP parameter 
file, MAKER2 produces exon level accuracies of 53.69%; whereas when using the 
correct parameter files outside of MAKER2, the programs GeneMark, SNAP, and 
Augustus produce exon level accuracies of 47.31%, 47.01%, and 61.37%, respectively. 
The level of improvement seen suggests that for second-generation genome projects 
where training data may be limited or of poor quality, running ab initio gene-
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predictors as part of an evidence based pipeline like MAKER2 can provide 
substantial benefits in performance.  
Gene prediction/annotation in second-generation genomes 
When analyzing the performance of gene-predictors in sequenced second-
generation genomes, the same metrics of sensitivity, specificity, and accuracy used 
for first-generation genomes cannot be applied (Table 2.1). This is because second-
generation genomes lack the high-quality reference gene models required to 
calculate these values (accuracy measures the overlap between a prediction and the 
supposed correct reference). Therefore we are forced to apply a different metric. 
In the experiments below, we use Pfam[31] domain content (mapped using 
InterProScan[32]) as a proxy metric for annotation quality. Although expansion and 
contraction of gene families can be an important mode of organism evolution, the 
high level of domain content of eukaryotic proteomes is relatively invariant[33]; this 
fact can be clearly seen in Table 2.5, which documents the high-level Pfam domain 
frequencies for six different well annotated eukaryotic model organisms (H. sapiens, 
M. musculus, D. melanogaster, C. elegans, A. thaliana, and Saccharomyces 
cerevisiae[34]). This relative invariance in the domain content of eukaryotic 
proteomes can be used as the basis for a rough standard with which to assess the 
accuracy of a second-generation genome’s annotations. 
At the grossest level of resolution, the percentage of annotations containing 
one or more Pfam domains provides an indication of accuracy. Alternatively the 
relative frequencies of different types of domains can be used to provide an even 
more precise measure, but such analyses must be considered with caution as there is 
always the possibility that some new, exotic second-generation genome may exhibit 
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divergent relative domain frequencies – even though these are grossly static at the 
whole-proteome scale for every published genome we have examined (Table 2.5).  
To compare the performance of ab initio gene prediction algorithms to that of 
MAKER2 on second-generation genomes, we performed the proof-of-principle 
genome annotation of Schmidtea mediterranea (flatworm) and Linepithema humile 
(Argentine ant). For this analysis, we used the ab initio gene-predictor SNAP 
because it can be easily trained for new genomes using CEGMA[35] (an HMM-based 
program that identifies and annotates a subset of highly conserved, universal 
eukaryotic genes). The gene models produced by CEGMA then serve as the initial 
training set for SNAP. MAKER2 annotation of S. mediterranea also integrated 
mRNA-seq reads from that organism into the pipeline thus demonstrating how next-
generation transcriptome data can be used to improve gene models (see Methods). 
Figure 2.1a gives the high level breakdown of domain contents for six 
reference genomes. On average, 68% of annotations in these six genomes contain a 
Pfam domain. For individual proteomes, the percent enrichment ranges from a low 
of 57% for C. elegans to a high of 78% for M. musculus. In contrast, only 15% of 
SNAP produced ab initio gene predictions in L. humile contain a Pfam domain 
(Figure 2.1b), and in S. mediterranea the percent enrichment is even lower at just 
6% (Figure 2.1c). The MAKER2-based proteomes, by comparison, are highly 
enriched for domains (Figure 2.1c). In total, 56% of the L. humile and 52% of S. 
mediterranea MAKER2-supervised SNAP predictions contain Pfam domains (values 
far more similar to the 68% enrichment seen in the reference proteomes). 
Interestingly, not only are domain counts low for the SNAP ab initio 
predictions, but the gene counts produced for both species are well above what is 
expected for both organism. Approximately 15,000 genes are expected for S. 
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mediterranea and approximately 17,000 are expected for L. humile [6, 9], both 
values well below the 63,622 and 420,224 gene predictions produced (respectively) 
when running SNAP on its own (outside of MAKER2). Ab initio gene-predictors have 
a recognized tendency to over predict[23], and as these results demonstrate, this 
tendency can be greatly exacerbated by limited data. In contrast, MAKER2’s 
supervised SNAP-based gene counts are dramatically more consistent with the 
published expected counts. MAKER2 produce 13,785 gene annotations for L. humile 
and 17,883 for S. mediterranea (Note this is even without further optimization and 
training of the gene-predictor SNAP). 
These results stand in stark contrast to the great accuracy obtained by SNAP 
on model organism genomes presented in Table 2.1. They also make it clear that 
when training data are limited or of low quality, ab initio gene-predictors produce 
much more reliable results when supervised by an evidence based pipeline like 
MAKER2. This conclusion is also consistent with our earlier analyses where we 
annotated three model organism genomes using unmatched species parameter files 
(Table 2.3). Additionally MAKER2’s use of mRNA-seq reads for annotating S. 
mediterranea demonstrates that these types of next-generation techniques can be 
effectively utilized to improve final gene models. 
Annotation Edit Distance as a quality control metric 
As the number of published genomes continues to expand, the resources and 
manpower dedicated to the maintenance of existing genome annotations is being 
spread thinner and thinner. Manual curation and validation of every annotation in 
every genome is therefore simply infeasible. A more practical approach would be to 
dedicate limited resources and manpower to curation and validation of only those 
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gene annotations most in need of improvement. As we demonstrate below, MAKER2 
provides an effective means for automated quality control of genome annotations. 
Even in cases where the administrators of genome databases have no plans to 
undertake manual curation, quality control measures are still desirable, as they 
provide a means for downstream users to judge the quality of an annotation before 
proceeding with experiments that depend upon the annotation’s accuracy for 
success. Identifying low quality gene annotations however is a challenge not well 
addressed by existing tools. While quality metrics such as sensitivity, specificity, and 
accuracy are convenient for evaluating the performance of gene-predictors, they 
presuppose the existence of reference gene models against which to compare each 
annotation; this precludes their use in quality control of second-generation genome 
annotations. Researchers working with second-generation annotations are thus in 
need of new quality control measures and annotation management tools.  
To address this issue, we have adapted the Annotation Edit Distance 
(AED)[20] measurement, developed by the Sequence Ontology, for use in MAKER2 
as an annotation quality control metric. The AED metric is an extension of the 
sensitivity and specificity measures used to judge gene-finder performance[24], but 
it differs in that no reference is used. Instead AED measures the distance between 
two annotations (each from a different releases of the same genome), and it makes 
no assumptions as to which one is the more correct. As originally formulated, AED 
provides a means to measures changes to a gene annotation from release to release. 
We have adapted AED for use in MAKER2 as a means to quantify the distance 
between a gene annotation and its supporting evidence – EST, protein, and mRNA-
seq alignments (see Methods for details). As we show in the analyses presented 
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below, MAKER2’s AED values provide a useful measure for annotation quality 
control.  
AED values are bounded between 0 and 1, with a value of 0 indicating an 
exact match between an annotation and its evidence and 1 indicating no evidence 
support. Thus, AED can be used as a rational basis for how much faith should put in 
an annotation before proceeding with downstream bench experiments, and database 
managers can use AED to sort gene models from best supported to worst in order to 
prioritize them for downstream manual review. 
As proof-of-principle, we compared MAKER2 produced AED scores for every 
annotation in release 30 of the M. musculus reference annotations (2003) to those of 
release 37.1 (2007) (Figure 2.2). We also performed the same analysis using 
reference annotations from human releases 33 (2003) compared to human release 
37.2 (2010) (Figure 2.3). In order to perform this analysis, we used MAKER2 to align 
EST and protein homology evidence against reference annotations from mouse 
releases 30 and 37.1 and human releases 33 and 37.2 (thus producing AED scores 
for all annotations in the two datasets). We then plotted the cumulative distribution 
of AED for each dataset (Figure 2.2c and 2.3c). As can be seen in mouse release 30, 
there exists an abundance of genes with limited evidence support (large portion of 
genes with high AED values). In contrast, for the more recent mouse release 37.1, 
the AED distribution is shifted toward lower AED (better) values. These two curves 
thus provide a high-level quantitative overview of the genome-wide improvements to 
the mouse gene-annotations between 2003 and 2007. 
Notably, many of the release 33 mouse annotations nearly or completely lack 
support from EST and protein homology (as indicated by a spike of genes distributed 
around the AED value of 1). In contrast, for the more recent mouse release 37.1, 
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there is nearly a complete elimination of the spike of gene around AED score 1; its 
absence suggests that the earlier releases contained an abundance of false positive 
gene predictions that were deleted by release 37.1.  
To further explore the extent to which AED scores are indicative of 
annotation quality, we also investigated the AED distribution of the highest quality 
subset of reference GenBank annotations from each of the mouse and human 
genome releases (the highest quality genes are those with NM prefixes assigned by 
RefSeq[36, 37]) (dotted lines in Figure 2.2c and Figure 2.3c). The RefSeq NM prefix 
provides us with an independently identified ‘gold-standard’ dataset of best quality 
annotations for comparison. For all releases, we see that the ‘gold-standard’ NM 
annotation datasets produce cumulative AED distributions that are shifted toward 
lower AED scores than the reference sets they are derived from. This indicates that 
MAKER2 is able to both quantify and verify the higher quality of these genes, 
providing further support for its use as a tool for annotation quality control. 
We also investigated how well AED scores agreed with Pfam domain content. 
As can be seen in Figure 2.2a and Figure 2.3a, AED scores accord well with domain 
content. In mouse release 30, for example, 87% of genes with AED scores from 0 to 
0.25 contain a know domain, whereas only 44% of genes with an AED score ranging 
from 0.75 to 1.0 contain a domain. The trend is even more striking in human release 
33 where only 15% of annotations with AED scores between 0.75 and 1.0 contain a 
domain, suggesting the abundance of false positive gene predictions in that subset of 
genes (Figure 2.3a). Tracking these annotations across releases supports this 
hypothesis: 86% of genes from human release 33 with AED scores between 0.75 and 
1.0 are absent by release 37.2 (Figure 2.3b). The same trend is observed in mouse: 
59% of annotations in release 30 with AED scores between 0.75 and 1.0 were deleted 
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by release 37.1 (Figure 2.2b). In comparison, only 14% of genes with AED scores 
between 0 and 0.25 were deleted between mouse release 30 and release 37.1. 
Collectively, these results show that gene annotations judged to be of low quality by 
MAKER2 were also judged to be of low quality by GenBank and preferentially 
deleted (demonstrating that AED scores mirror the independent curation decisions 
made by the mouse and human research communities). These facts demonstrate the 
utility of MAKER2 as an annotation management tool. 
Re-annotation of existing genomes and legacy annotation sets 
While there are a large number of second-generation genome projects 
underway, falling sequencing costs are also leading many researchers to revisit 
published genomes to improve gene models in light of new evidence (such as mRNA-
seq) or to take advantage of newer, more complete genome assemblies. There are 
also instances where researchers are sequencing individual strains/mutants of 
organisms where a published reference genome is already available or where 
multiple sets of legacy annotations exist and they wish to carry over annotations 
from the reference genome and merge them into a nonredundant consensus dataset. 
MAKER2 provides a simple method to perform these tasks via an external 
annotation pass-through mechanism that accepts as input any pre-existing genome 
annotations as well as aligned experimental evidence provided in a GFF3 formatted 
file (i.e., if the user supplies MAKER2 with gene models or pre-aligned experimental 
evidence in GFF3 format, that data will merge seamlessly into the pipelines existing 
analysis). 
When using this GFF3 pass-through mechanism, MAKER2 takes the user 
provided gene models (from GFF3 files), aligns any additional experimental evidence 
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against the genome (from standard FASTA files), and then calculates quality control 
statistics such as AED. If the user supplied MAKER2 with more than one legacy 
annotation dataset (i.e., multiple GFF3 files of alternate legacy annotations), 
MAKER2 chooses the one model most consistent with the evidence for each locus 
and carries it forward into the consensus dataset (nonredundant). Researchers can 
also select to run ab initio gene-predictors (as is done for de novo annotation) in 
addition to providing a GFF3 file of legacy annotations. In this case, MAKER2 can 
produce new gene models for regions where the evidence suggests the existence of a 
gene that was not found in the legacy set, and with the help of the gene-finders 
MAKER2 can try and update/revise the legacy annotations to better account for 
features suggested by aligned evidence. 
As proof-of-principle of MAKER2’s model pass-through and re-annotation 
capabilities, we used the pipeline to process a 22 megabase region of maize inbred 
line B73 chromosome 4[38] together with version 5a.59 of the MaizeSequence.org 
Working Gene Set[39]. For maize chromosome 4, we produced a de novo annotation 
gene set, a pass-through dataset (in which all reference annotations were 
maintained but tagged with evidence associations and AED values), and a re-
annotation dataset (wherein MAKER2 was allowed to maintain or update reference 
annotations based on aligned experimental evidence). The cumulative distribution of 
AED scores for these three datasets was then graphed and is shown in Figure 2.4c. 
We also plotted the AED distribution of the high quality subset of reference 
annotations from the Maize Classical Gene List[40] for comparison as an 
independently identified ‘gold-standard’ control dataset (Figure 2.4c, gold curve). 
During re-annotation, 304 out of 493 version 5a.59 reference gene models 
were altered/updated to reflect features suggested by evidence alignments; 88 new 
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gene models were produced for regions where the evidence suggested the existence 
of a gene but no model existed; and 189 reference gene models were left unchanged. 
A total of 89 of the unmodified reference gene models had no evidence support and 
were prioritized by MAKER2 for manual review as possible false positive 
annotations. Alterations to gene models during the re-annotation process caused the 
AED distribution curve for the re-annotation dataset (Figure 2.4c, purple curve) to 
shift towards lower AED values (better) relative to the reference annotation set 
(Figure 2.4c, red curve). This shift suggests that re-annotation using MAKER2 
successfully brought gene models more in line with experimental evidence, thus 
improving their quality. A further comparison of both the re-annotation dataset and 
the unmodified reference dataset to the ‘gold-standard’ annotation set (Figure 2.4c, 
gold curve) supports this conclusion as these high quality gene models also tend to 
be distribute around lower AED values (with more than 80% of ‘gold-standard’ 
annotations having AED values of < 0.2 compared to just 40% for the version 5a.59 
reference annotation set). The spike in the AED distribution for both the unmodified 
reference dataset and the re-annotation dataset represents gene models that have 
little-to-no evidence support and are prioritized by MAKER2 for manual review. In 
comparison, the de novo annotation set (Figure 2.4c, blue curve) has an AED 
distribution shifted toward lower values than either the re-annotation or reference 
dataset; this is primarily due to the exclusion of unsupported gene models as the 
average AED for both the de novo and re-annotation datasets is identical when 
unsupported models are excluded (average AED of 0.17 in both). 
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Managing existing annotation databases 
With the proliferation of existing sequencing data, researchers have access to 
published genomes of multiple related species that may have been annotated using 
very different methods and to varying degrees of quality. Here, we evaluate how 
MAKER2’s annotation pass-through option can be used to map cross-species data to 
multiple related genomes. We also explore how these data can be used to fuel 
downstream analyses such as cross-species orthology. 
We used MAKER2 to map experimental evidence as well as reference 
annotations to six published ant genomes: Atta cephalotes[7], Pogonomyrmex 
barbatus[8], L. humile[9], Harpegnathos saltator[41], Camponotus floridanus[41], 
and Solenopsis invicta[18]. The protein datasets provided to MAKER2 consisted of 
all proteins from UniProt/Swiss-Prot, D. melanogaster, Nasonia vitripennis 
(wasp)[42], Apis mellifera (honey bee)[43], and each of the previously mentioned 
published ant species (the individual species whose genome was being evaluated was 
always excluded from the protein dataset). We also included all Apocrita and 
Formicidae ESTs in dbEST[44] with the EST dataset. Resulting cumulative AED 
distributions were then plotted for each ant species; average percent orthology and 
domain content were also evaluated for each quartile of the AED distribution 
(Figure 2.5). 
Low AED scores indicate gene models that are more in agreement with 
evidence alignments while higher values mean less evidence support. The 
cumulative distribution of AED scores for the six ant species can be seen in Figure 
2.5c. For each ant species, there is a spike in the distribution curves around AED 
score 1. This spike represents genes that MAKER2 has prioritized for manual 
review. We see in Figure 2.5a that Pfam domain content is well correlated with AED 
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score, and an average of 63% of genes with scores between 0 and 0.25 contain a Pfam 
domain compared to only 11% of genes with scores between 0.75 and 1.0. The low 
domain enrichment suggests that genes prioritized by MAKER2 are most likely false 
positive gene predictions, but there is also the potential that these represent novel 
genes with domains that would not be found in the Pfam domain database. If we 
further expand our analysis to look at orthology among the ant species, we see that 
percent orthology between the six ant species is well correlated to AED. For 
example, 94% of genes with AED scores between 0 and 0.25 have orthology to at 
least one protein in another ant species (on average there are 4.41 orthologous genes 
in other ant species that associate back to each of these), whereas only 26% of genes 
with AED scores between 0.75 and 1.0 have at least 1 ortholog in another ant 
species (for the genes here that have an ortholog there are only 1.85 orthologs that 
map back to them on average). Together with the domain analysis, the association of 
AED and orthology suggests that genes with AED scores near 1 are indeed false 
positive gene predictions, thus supporting the use of the AED statistic for quality 
control. The correlation of AED to orthology also suggests that AED could be used as 
a selection tool for identifying genes sets for downstream experimentation with well 
conserved genes shared across species more likely to group around low AED values. 
Because the annotations and evidence are all loaded into a database ready output 
format, researchers can also view MAKER2 cross-species alignments in GMOD tools 
like GBrowse and Apollo, which would allow them to explore more detailed aspects 
of cross-species conservation such as presence/absence of exons and introns. 
The ability of MAKER2 to align cross-species data to multiple genomes in 
this way demonstrates how MAKER2 can be used to generate common resources 
even when genomes are annotated using very different methods. Because all 
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annotations and experimental evidence have been processed into a common format, 
they can now be easily loaded into downstream GMOD tools for analysis and data 
distribution. MAKER2 thus provides an efficient automated mechanism for research 
communities and organizations to manage shared genome database resources. 
High-throughput parallelization 
MAKER2 has been optimized to support high-throughput parallelization 
using Message Passing Interface (MPI), a distributed cluster communication 
protocol. To explore how data throughput in MAKER2 scales with processor usage, 
we annotated the 10 megabase NGASP[23] dataset for C. elegans using an 
increasing number of processor cores (Figure 2.6). We see from the analysis that 
data throughput scales linearly with processor usage, annotating the entire 10 
megabase dataset in just under 1 hour on 32 CPU cores; this means MAKER2 
should be able to annotate the entire C. elegans genome in less than 10 hours using 
similar settings. Researcher with access to distributed computer clusters (300-3000 
CPU cores) could expect to annotate even human-sized genomes (~2-3 gigabases) in 
less than 24 hours, while smaller fungal sized genomes (~40-80 megabases) could 
easily be annotated on laptop or desktop machines in the same time period. The 
scalability of data throughput for MAKER2 therefore allows researchers to process 
datasets of virtually any size or to process multiple datasets in a timely manner. 
MAKER2’s high-throughput parallelization also provides a potential solution to the 
problem of annotating ultra large genomes such as pine trees, which have genomes 
in the 20-30 gigabase range[13]. 
It is important to note that much of MAKER2’s computation time is spent 
aligning experimental evidence to the genome and analyzing the results. For this 
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reason, the overall time required for genome annotation is expected to vary not only 
with genome length but also with the size of the input experimental evidence 
dataset. This upfront investment in computation time, however, provides enormous 
benefits downstream as all supplied EST reads, protein homology data, and gene 
predictions are available as searchable features in the final output. By loading 
MAKER2’s output into GMOD tools like Chado[45], Galaxy[46], and GBrowse[47], 
researchers can quickly perform downstream analyses such as exploring protein 
orthology and analyzing sequence conservation. They can also identify cross-species 
changes in intron exon structures with the advantage of having all the information 
available directly from MAKER2’s output without having to perform any additional 
computation. 
Conclusions 
MAKER2’s annotation of the classic model systems D. melanogaster, C. 
elegans, and A. thaliana demonstrates that the accuracy of gene models produced by 
MAKER2 is comparable to that produced by other existing tools (ab initio gene-
predictors). We also see that with enough training, HMM based ab initio gene 
prediction algorithms can perform as well, if not better, than more computationally 
intensive evidence-based annotation pipelines like MAKER2. This has previously 
been seen in genome annotation competitions like NGASP[23]. However, the 
performance of ab initio gene-predictors is heavily dependent on the availability of 
extensive training data, and further analysis demonstrates the fallacy of expecting 
similar outcomes for emerging model organism genomes. 
First-generation (classic model organism) genome projects benefitted heavily 
from the extensive knowledge of genes and gene structure that was already 
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available before the genome projects even began. Unfortunately, second-generation 
(emerging model organisms) genomes, which represent the overwhelming majority 
of new sequencing projects, do not share the advantage of an extensive pre-existing 
knowledgebase. There are usually few if any pre-existing gene models, often no 
genetics; in fact, the genome project may be the primary resource to begin future 
research into these organisms. For genomes such as these, using ab initio gene-
predictors as part of an annotation pipeline, like MAKER2, produces better results 
(Figure 2.1). 
By aligning evidence from ESTs, mRNA-seq, and protein homology, MAKER2 
also provide a convenient way to add these types of experimental data to new and 
existing genome databases for downstream analysis or visualization in GMOD tools 
such as Apollo and GBrowse. Additionally, the association of evidence to gene 
models via the AED statistic provides a simple mechanism for focusing limited 
resources to the subset of genes most in need of review and manual curation. As 
proof-of-principle, we demonstrated that MAKER2 was able to prioritize genes for 
review from mouse release 30 and human release 33. This prioritization 
overwhelmingly correlates with the deletion and revision of the same genes in 
subsequent mouse release 37.1 and human release 37.2, indicating that AED 
prioritization closely emulates manual and automatic quality control methods used 
for these genomes. MAKER2 however provides the advantage of performing this 
type of quality control prioritization as a fully automated analysis that can be 
performed by individuals with little bioinformatics experience on both new and 
existing genome annotations. 
It is important to realize that the primary benefit of the aligned evidence and 
quality control statics produced by MAKER2 is that they allow researchers to make 
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more informed decisions when designing experiments. Researchers are often 
unaware of the confidence associated with a gene model, which can have potentially 
disastrous results as incorrect annotations poison every experiment that uses them. 
Methods 
De novo annotation of first-generation genomes 
D. melanogaster chromosome 3R and GFF3 annotations for release r5.32 
were downloaded from FlyBase. C. elegans chromosome V and GFF3 annotations for 
release WS221 were downloaded from WormBase. A. thaliana chromosome 4 and 
GFF3 annotations were downloaded from TAIR. Each set of reference gene 
annotations were passed to MAKER2’s model_gff option with all prediction and 
evidence alignment options turned off. This has the effect of repackaging the 
reference gene models into more standardized GFF3 files compatible with 
downstream analysis scripts. 
Ab initio gene predictions were produced by the programs SNAP version 
2010-07-28, Augustus 2.5.5, and GeneMark-ES 2.3a, using the D. melanogaster, C. 
elegans, and A. thaliana parameter files pre-packaged with each algorithm 
(GeneMark parameter files are packaged with the GeneMark.hmm download). To 
produce all predictions in standardized GFF3 format, these algorithms were run 
through MAKER2 with all evidence alignments options turned off and the 
keep_preds flag set to 1. This has the effect of only producing raw ab initio gene 
predictions in standardized GFF3 format. 
Evidence-based gene annotations in MAKER2 were produced using default 
settings. The species parameter files were the same as those used for the ab initio 
gene-predictors. EST and protein homology datasets were provided for each 
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organism. For D. melanogaster, the EST dataset consisted of all D. melanogaster 
ESTs available from dbEST, and the protein homology input consisted of all 
Anopheles gambiae proteins from NCBI together with all of the UniProt/Swiss-Prot 
database proteins (minus Drosophila proteins). For C. elegans, the EST dataset 
consisted of all C. elegans release WS221 ESTs available from WormBase, and 
protein homology input consisted of all Caenorhabditis briggsae WS221 proteins 
from WormBase together with all of the UniProt/Swiss-Prot database proteins 
(minus Caenorhabditis proteins). The EST dataset for A. thaliana consisted of all A. 
thaliana ESTs from dbEST, and the protein homology dataset consisted of all Oryza 
sativa release 6.1 proteins from PlantGDB and all of the UniProt/Swiss-Prot 
database proteins (minus Arabidopsis proteins). For A. thaliana, MAKER2 was also 
provided with the Arabidopsis transposable element FASTA file available from TAIR 
(assists in repeat masking). 
The reference gene models, ab initio gene predictions, and evidence-based 
gene annotations were converted to GTF format using the maker2eval script 
packaged with MAKER2. Values for sensitivity and specificity were then produced 
using Eval[30]. 
De novo annotation using unmatched species parameters 
To simulate non-optimal training of the ab initio gene-finders, ab initio 
predictions and MAKER2 annotations were produced for D. melanogaster, C. 
elegans, and A. thaliana using unmatched species parameter files. This was done by 
running SNAP, Augustus, GeneMark, and MAKER2 on C. elegans and D. 
melanogaster using the A. thaliana parameter files. These programs were then run 
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on A. thaliana using the C. elegans parameter files. All other steps and procedures 
were identical to the previous analysis. 
De novo annotation of second-generation genomes 
S. mediterranea assembly 3.1 and L. humile assembly 4.0 were used to 
evaluate the performance of the ab initio gene-predictor SNAP and the annotation 
pipeline MAKER2 on second-generation genome projects. To produce SNAP required 
parameter files for each species, we first ran CEGMA, which produces gene models 
that can be used for training SNAP from a core set of universal genes that should be 
found in all eukaryotes. CEGMA gene models were converted to SNAP required ZFF 
format using the cegma2zff script that comes bundled with MAKER2. SNAP was 
then trained in accordance with its documentation.  
To produce all predictions in standardized GFF3 format, SNAP was ran via 
MAKER2 with all evidence alignments options turned off and the keep_preds flag 
set to 1. This has the effect of only producing raw ab initio gene predictions in 
standardized GFF3 format. 
MAKER2 was run on S. mediterranea using an EST dataset consisting of all 
ESTs available for S. mediterranea found in dbEST together with the SmedGD EST 
dataset[6, 17]. The protein homology dataset consisted of all proteins in the 
UniProt/Swiss-Prot protein database, all Schistosoma mansoni v4.0 proteins from 
Sanger, and all GenBank proteins for Nematostella vectensis, H. sapiens, C. 
elegans, and S. mediterranea. The SmedGD repeat library was also used[6, 17]. 
Short read mRNA-seq transcriptome datasets for S. mediterranea were 
downloaded from the NCBI Sequence Read Archive (SRP006000). TopHat[48] v1.2.0 
and Cufflinks[49] v0.9.3 were used to align and process these short reads. The script 
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tophat2gff3 and cufflinks2gff3 were then used to process the results into GFF3 
format. The resulting GFF3 files were provided to the est_gff option in MAKER2. 
MAKER2 was run on L. humile using the published genome project EST[9] 
dataset together with all Apocrita and Formicidae ESTs available from dbEST. The 
protein homology dataset consisted of all of the UniProt/Swiss-Prot protein 
database, D. melanogaster r5.32 proteins, N. vitripennis OGS 1.2 proteins, A. 
mellifera OGS 2 proteins, and all Formicidae proteins from GenBank. A combined 
repeat FASTA file from the published L. humile and P. barbatus genomes was also 
provided[8, 9]. 
Pfam domain analysis 
InterProScan[32] was used to identify Pfam[31] domains for all gene 
prediction/annotation datasets. Domains were filtered to remove reverse 
transcriptase, integrase, and virus related protein domains. Any domain listed as 
unknown, uncharacterized, or NULL was ignored. 
To explore the upper bound of expected Pfam domain content in a newly 
annotated genome, we used InterProScan to identify Pfam protein domains in H. 
sapiens release 37.2, M. musculus release 37.1, D. melanogaster r5.32, C. elegans 
WS221, and S. cerevisiae (NCBI release). Domains were filtered as before (i.e. 
remove reverse transcriptase, integrase, and virus related domains). The average 
domain enrichment for these reference genomes was then calculated for comparison. 
Calculating Annotation Edit Distance 
Sensitivity, specificity, and accuracy are commonly used metrics for 
evaluating the performance of gene prediction algorithms by comparing the 
38 
 
resulting gene prediction to a well-supported reference annotation[50]. Sensitivity is 
defined as the fraction of a reference overlapping a prediction; specificity is defined 
as the fraction of a prediction overlapping a reference; and accuracy is commonly 
defined as the average of sensitivity and specificity (although several alternate 
formulations exist). Both sensitivity and specificity can be calculated for any feature 
in the genome at different levels of stringency (i.e., base pair level, exon level, etc.). 
Given a gene prediction i and a reference j, the base pair level sensitivity can 
be calculated using the formula SN = |i∩j|/|j|; where |i∩j| represents the number 
overlapping nucleotides between i and j, and |j| represents the total number of 
nucleotides in the reference j. Alternatively, specificity is calculated using the 
formula SP = |i∩j|/|i|, and accuracy is the average of the two. 
When calculating Annotation-Evidence Distance, we adapt the calculation of 
sensitivity and specificity to account for the fact we do not have a reference gene 
model for comparison; instead, we cluster experimental evidence aligned against the 
genome to approximate the reference. So for SN = |i∩j|/|j|, the value |i∩j| 
represents the number of nucleotides in a gene prediction overlapped by 
experimental evidence, and |j| represents the total base pair count for experimental 
evidence in that cluster. Because we are not comparing to a high quality reference, it 
is more correct to refer to the average of sensitivity and specificity as the congruency 
rather than accuracy; where C = (SN+SP)/2. The incongruency, or distance between i 
and j, then becomes D = 1-C, with a value of 0 indicating complete agreement of an 




AED evaluation for the human and mouse genomes 
H. sapiens annotations for releases 33 and 37.2 as well as M. musculus 
annotations for releases 30 and 37.1 were downloaded from NCBI in GenBank file 
format. They were converted to GFF3 format using the genbank2gff3 script 
available in the BioPerl[51] 1.6 distribution. The resulting GFF3 files were passed to 
MAKER2’s model_gff option with all prediction and evidence alignment options 
turned off. This has the effect of repackaging the gene models into more 
standardized GFF3 files compatible with downstream analysis scripts. 
The standardized GFF3 files were then provided to MAKER2’s model_gff 
option once again together with protein and EST datasets to produce downstream 
quality control metrics for each gene model. The human reference gene annotations 
were processed using all human ESTs from dbEST and a protein dataset consisting 
of all mouse proteins together with all of UniProt/Swiss-Prot (minus human 
proteins), and the genome was masked using the mammal subset of repeats from 
RepBase. The mouse reference gene annotations were processed using all mouse 
ESTs from dbEST and a protein dataset consisting of all human proteins together 
with all of UniProt/Swiss-Prot (minus mouse proteins), and the genome was masked 
using the mammal subset of repeats from RepBase. 
The presence/absence of human release 33 genes in release 37.2 and mouse 
release 30 genes in release 37.1 was determined using BLASTP and reciprocal best 
hits analysis (where genes from each dataset are each others best hit). A threshold 
e-value of 1x10-6 was required for all hits. Pfam domains were also mapped to all 
genes using the previously described methodology. 
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Re-annotation of the maize genome 
To demonstrate MAKER2’s ability to re-annotate existing genomes with 
respect to legacy annotations, we re-annotated a 22 megabase region of the Zea 
mays (maize) inbred line B73 chromosome 4, available from MaizeSequence.org. We 
then used the subset of reference annotations that are also included in the Maize 
Classical Gene List[40] as a ‘gold standard’ set to evaluate MAKER2’s performance. 
We first produced a standardized GFF3 file for the maize reference 
annotations by using the map2assembly script bundled with MAKER2 to map maize 
reference transcripts onto the genome. We then provided the resulting GFF3 file to 
MAKER2 via the model_gff option and provided an EST dataset consisting of all 
ESTs/cDNAs for maize available from the Maize Full Length cDNA Project[52] and 
dbEST. The protein homology dataset we used consisted of the A. thaliana proteome 
and all of the UniProt/Swiss-Prot database (minus any maize proteins). Maize 
specific repeats were acquired from the Maize Transposable Element Database[53]. 
The resulting MAKER2 output was a GFF3 file containing AED quality control 
values for all reference transcripts. The AED distribution of the reference was then 
graphed together with the AED distribution for the ‘gold standard’ genes identified 
as overlapping the Maize Classical Gene List. 
Next we produced de novo annotation and a re-annotation dataset using 
MAKER2. The de novo annotation dataset was produced using the maize prediction 
parameter file that comes bundled with SNAP. We also provided MAKER2 with the 
same EST, protein, and repeat datasets used in the previous analysis. To produce 
the re-annotation dataset, we again used the same EST, protein, repeat, and SNAP 
files; however, we also passed MAKER2 all legacy annotations by indicating the 
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location of the reference GFF3 file in the model_gff option. We then graphed the 
AED distributions as was done previously for the reference dataset. 
Evidence alignment and analysis of published ant genomes 
To demonstrate how MAKER2 can be used to add experimental evidence and 
quality control statistics to existing genome databases (which can fuel downstream 
analyses or be used to improve annotations), we used MAKER2 to add cross-species 
homology data to six published ant genomes. We downloaded annotations for A. 
cephalotes OGS 1.2, L. humile OGS 1.2, P. barbatus OGS 1.2, C. floridanus v3.3, H. 
saltator v3.3, and S. invicta v2.2.0 from the Hymenoptera Genome Database[43]. 
Most species had GFF3 format annotations that were passed to MAKER2’s 
model_gff option, with all prediction and evidence alignment options turned off. This 
has the effect of repackaging the gene models into more standardized GFF3 files 
compatible with downstream analysis scripts. For S. invicta, however, we used the 
map2assembly script bundled with MAKER2 to map transcripts onto the genome 
assembly (thus producing a standardized GFF3 formatted annotation file). 
We next ran MAKER2 on each of the six ant species. Standardized GFF3 files 
were passed to MAKER2’s model_gff option. We used an EST dataset consisting of 
all Apocrita and Formicidae ESTs available from dbEST (this did not include ESTs 
for any of the six species being analyzed). We used a protein homology dataset 
consisting of all of the UniProt/Swiss-Prot protein database, D. melanogaster r5.32, 
N. vitripennis OGS 1.2, A. mellifera OGS 2, and all of the published ant proteomes 
(always excluding the species being processed at the time). A combined ant repeat 




Orthology of the six ant species was explored using BLASTP and reciprocal 
best hits analysis. A threshold e-value of 1x10-6 was required for all hits. We also 
used InterProScan to identify Pfam domains for all proteins using the previously 
described methodology. 
Evaluation of high through-put parallelization 
The parallelization performance of MAKER2 was evaluated on a server with 
four, twelve-core AMD Opteron 6174 Processors (48 total CPU cores) running Red 
Hat Enterprise Linux Server release 5.5. MAKER2 was configured with default 
settings and the NGASP protein, EST, and genomic sequence datasets available 
from WormBase. The NGASP genomic sequence is a selected 10 megabase sampling 
of the C. elegans genome (release WS160). We ran MAKER2 (the parallel executable 
is mpi_maker) using 1, 4, 8, 16, and 32 CPU cores under MPICH2 1.3.1. The Linux 
time command was used to evaluate process run time. 
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Figure 2.1 MAKER2 vs. ab initio  predictors on second-generation genomes. 
We compared the performance of the ab initio predictor SNAP to the annotation 
pipeline MAKER2 on two second-generation genomes: L. humile (Argentine ant) and 
S. mediterranea (flatworm). Pfam domain content was used as a means to evaluate 
the performance of these algorithms, under the assumption that a poorly annotated 
genome will be globally depleted for domains relative to well-annotated genomes. (A) 
The average Pfam domain contents for six well annotated eukaryotic reference 
proteomes: H. sapiens, M. musculus, D. melanogaster, C. elegans, A. thaliana, and 
S. cerevisiae. These data provide an upper bound for the expected domain content of 
a newly sequenced genome. The region of the pie chart outlined in red indicates the 
percentage of genes containing a Pfam domain; these are further subdivided by GO 
molecular function. (B) The Pfam domain content of SNAP produced ab initio 
predictions compared to MAKER2-SNAP gene annotations for the L. humile 
genome. (C) The Pfam domain content of SNAP ab initio gene predictions and 






























































Figure 2.2 Evaluating AED as a metric for annotation quality control. 
Annotation Edit Distance (AED) provides a measurement for how well an 
annotation agrees with overlapping aligned ESTs, mRNA-seq and protein homology 
data. AED values range from 0 and 1, with 0 denoting perfect agreement of the 
annotation to aligned evidence, and 1 denoting no evidence support for the 
annotation. We evaluated the use of AED as a quality control metric by comparing 
MAKER2 produced AED scores for release 30 (2003) of the M. musculus genome to 
the AEDs for release 37.1 (2007). These data show how AED can be used to quantify 
improvements to the annotations between each release. (A) The Pfam domain 
content of M. musculus release 30 for genes found in each quartile of the MAKER2 
AED distribution. Note that genes with low AEDs are highly enriched for domains. 
(B) The fraction of M. musculus genes from release 30 maintained/removed from 
subsequent release 37.1 for each MAKER2 AED distribution quartile. These data 
show how AED mirrors the independent curation decisions made by the mouse 
research community between 2003 and 2007. (C) The cumulative AED distributions 
of M. musculus release 30 and 37.1 demonstrate how AED quantifies improvements 
made between releases. The subset of genes with NM prefixes assigned by RefSeq 
(which indicates the highest level of annotation quality) is plotted separately to show 
that these independently identified ‘gold-standard’ gene annotations tend to have 
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Figure 2.3 AED evaluation of Homo sapiens  reference annotations. 
Annotation Edit Distance (AED) provides a measurement for how well an 
annotation agrees with its associated evidence, as regards its overlap relative to 
aligned ESTs, mRNA-seq and protein homology data. AED values range from 0 to 1, 
with 0 denoting perfect agreement of the annotation to aligned evidence, and 1 
denoting no evidence support for an annotation. We evaluated the use of AED as a 
quality control metric by comparing MAKER2 produced AED scores for release 33 
(2003) of the H. sapiens genome to the AEDs for release 37.2 (2010). These data 
show how AED can be used to quantify improvements to annotations between 
releases. (A) The Pfam domain contents of H. sapiens release 33 for genes found in 
each quartile of the MAKER2 AED distribution. Note that genes with low AEDs are 
highly enriched for domains. (B) The fraction of H. sapiens genes from release 33 
maintained/removed from subsequent release 37.2 for each MAKER2 AED 
distribution quartile. These data show how AED mirrors the independent curation 
decisions made by the human genetics research community between 2003 and 2010. 
(C) The cumulative AED distributions of H. sapiens release 33 and 37.2 demonstrate 
how AED quantifies improvements made between releases. The subset of genes with 
NM prefixes assigned by RefSeq (which indicates the highest level of annotation 
quality) is plotted separately to show that these independently identified ‘gold-
standard’ gene annotations tend to have lower AED values in comparison to all 
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Figure 2.4 Re-annotation of a portion of the maize genome using MAKER2. 
Annotation Edit Distance (AED) provides a measurement for how well an 
annotation agrees with its associated evidence (see text and Figure 1 for additional 
details). Shown are cumulative AED distributions for several maize annotation 
datasets. Gold curve: AED distribution of high-quality ‘gold standard’ annotations in 
the benchmark region that are members of the J. Schnable and M. Freeling Maize 
Classical Genes List; These genes generally have the lowest AEDs. Red curve: all 
maize gene models from the MaizeSequence.org 5a.59 Working Gene Set in the 
benchmark region; Blue curve: MAKER2’s first pass, de novo annotations for the 
benchmark region; note that these genes generally have lower AEDs than the 5a.59 
Working Gene Set (red curve). Purple curve: automatic MAKER2-based 
update/revision of the maize 4a.53 Working Gene Set annotations. Note that the 








































Figure 2.5 MAKER2 as a management tool for existing genome annotations. 
MAKER2 was used to add cross species homology evidence and AED values to six 
published ant species. These data show how MAKER2 can be used both to add new 
data to existing datasets and for downstream prioritization of genes in those 
datasets for further analysis and curation. (A) The Pfam domain content in each 
AED quartile. Genes receiving higher AED scores are less likely to contain a 
domain, thus prioritizing them as possible false positive gene predictions. (B) The 
percent of genes in each AED quartile having an orthologous protein in a related ant 
species with the average number of orthologs per gene (for the subset of orthologous 
genes) listed at the bottom. AED score is highly correlated with orthology. (C) The 
cumulative AED distribution for all six ant species. The spike of genes with AED 
score at or near 1 suggests potential false positive genes predictions rather than 
species-specific genes, as these annotations also generally lack EST support and 






















)C",'C" $,C"+$C" &)C")'C" *'C"%)C"





































Figure 2.6 MAKER2 scales to even the largest genomes 
MAKER2 was used to annotate a 10 megabase section of the C. elegans genome 
(NGASP dataset). The algorithm was parallelized using MPI on an increasing 
number of CPU cores. This demonstrates how MAKER2 scales almost linearly with 
CPU number (with a slope of near 1). If we project our results forward to the entire 
C. elegans genome (~100 megabases), MAKER2 should take under 10 hours on 32 
CPUs to complete; similarly, the human genome (~3 gigabases) would require fewer 
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CHAPTER 3 
THE PROOF-OF-PRINCIPLE ANNOTATION OF EIGHT 
EMERGING MODEL ORGANISM GENOMES 
Introduction 
Genome databases and the annotations they contain are invaluable resources 
that facilitate research and discovery. While MAKER2 and related tools developed 
for MAKER2 do not test hypotheses directly, they facilitate and promote the broad 
acceleration of research by producing feature-rich genome annotations that act as 
substrates for further computational and experimental work. 
Here, I describe the proof-of-principle annotation of eight emerging model 
organism genomes using MAKER2, thus contributing critically to the understanding 
of their evolutionary history and functional biology. The annotation of these 
genomes was done in collaboration with their respective genome projects, and final 
genome annotations are all publicly available through those projects. 
Results and discussion 
Annotation of the necrotic plant pathogen Pythium ultimum 
Pythium ultimum var ultimum is a plant pathogen and a member of the class 
Oomycota (also referred to as Oomycetes). Oomycetes were at one time believed to be 
fungi because of their similar morphology and lifestyle; however, based on molecular 
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evidence, these organisms are now classified as part of the separate kingdom 
Chromalveolata, which is equidistant evolutionarily to animals, fungi, and plants[1]. 
Because of their unique position on the tree of life, the study of Oomycetes has the 
potential to reveal important insights into the history of eukaryotic evolution.  
The Pythium ultimum genome is not the first Oomycete to be sequenced. In 
fact there has been significant interest in studying this group of organisms primarily 
because they represent major pathogens affecting agriculturally important crops. 
Phytophthora infestans for example was the cause of the Irish potato famine, and 
was among the first Oomycete genomes to be sequenced[68]. Annotation databases 
for the Oomycetes Phytophthora sojae[2] and Phytophthora ramorum[2] also exist.  
One of the most interesting features of parasitic Oomycetes (and the primary 
focus of research in these organisms) is their use of secreted effector molecules which 
manipulate gene expression of a host to facilitate infection[3]. Study of these 
molecules may help elucidate the mechanisms used by Oomycetes for host infection 
and could potentially provide new solutions to protect agriculturally important crops 
from these pathogens. Pythium ultimum is basal evolutionarily to other sequenced 
Oomycetes (all of which belong to the phylum Phytophthora); therefore study of the 
Pythium ultimum genome has the potential to reveal trends in the evolution of this 
class of organisms especially with respect to their repertoire of secreted effector 
proteins.  
I used the program MAKER2 to annotate the Pythium ultimum genome, and 
produce a final annotation dataset consisting of 15,323 genes[4]. To evaluate the 
quality of the gene models, I compared the relative domain content of the Pythium 
ultimum proteome to that of other annotated Oomycetes and eukaryotic organisms 
(Figures 3.1 and 3.2). Previously, I have shown that a comparison of protein domain 
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content across organisms serves as a proxy metric for gene annotation quality (See 
the section in Chapter 2 titled ‘Gene prediction/annotation in second-generation 
genomes’). When comparing Pythium ultimum protein domain content to other 
organisms, I used InterPro domains (as opposed to Pfam domains) because InterPro 
is a comprehensive dataset and provides great sensitivity for detecting divergent 
protein domains. 
In the analysis of the Pythium ultimum proteome, 60% of genes contained at 
least one known InterPro protein domains (see Figure 3.1). In comparison the 
proteomes for Phytophthora sojae, Phytophthora ramorum, and Phytophthora 
infestans (all Oomycetes) contained 61%, 66%, and 55% domain enrichments, 
respectively (Figure 3.1). The relative similarities in protein domain content among 
related Oomycetes reflect well on the confidence associated with the Pythium 
ultimum gene annotations. InterPro domain enrichments for the proteomes of 
Aspergillus nidulans (fungi), Saccharomyces cerevisiae (fungi), and Arabidopsis 
thaliana (plant) in comparison are 73%, 81%, and 79%, respectively (Figure 3.2). The 
fact that other eukaryotes have higher domain enrichments in comparison to 
Oomycetes is not surprising because of the evolutionary isolation of Oomycota. 
Global analysis of the intron/exon structure in the Pythium ultimum genome 
reveals many interesting trends in Oomycete evolution. Exons in the Pythium 
ultimum genome tend to be relatively long when compared to other eukaryotes (they 
have an average length of 498 bp), and many genes are encoded by single-exon 
transcripts with extremely long open reading frames (the longest being 21,357 bp in 
length). Organisms like Drosophila melanogaster (animal) and Arabidopsis thaliana 
(plant) in comparison have average exon length of 380 bp and 234 bp, respectively. 
While there are examples of intron-rich genes in Pythium ultimum, the majority of 
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genes tend to have few introns (with an average 1.6 introns occurring per gene). 
Eukaryotes like D. melanogaster (animal) and A. thaliana (plant) in comparison 
contain an average of 5.1 and 5.4 introns per gene, respectively. Introns in Pythium 
ultimum also tend to be short (the average intron being 115 bp in length). Gene 
structure is thus similar to other Oomycetes like Phytophthora infestans (where the 
average intron is 124 bp in length, and the average gene contains 1.7 introns). 
Interestingly, homologs of large single exon Pythium ultimum genes tend to 
be intron rich in other eukaryotes. One example is midasin, a highly conserved ~600 
kDa nuclear chaperone protein. The Pythium ultimum ortholog of this gene is 
intronless; yet the same gene contains 72 introns in A. thaliana and 101 introns in 
Mus musculus (Figure 3.3). In Saccharomyces cerevisiae, however, this gene is 
encoded by a single exon, a striking similarity to Pythium ultimum considering the 
large evolutionary distance between fungi and Oomycetes. 
The tendency of Pythium ultimum genes to have few introns that are also 
short in length may be the result of evolutionary selection for quick production of 
proteins (since, in theory, short transcripts that undergo little to no splicing could be 
rapidly processed for translation). Consistent with this hypothesis, generation time 
has previously been shown to strongly correlate with intron length in many 
organisms[5]. The fact that large, single exon Pythium ultimum genes also tend to 
be single exon in fungi (despite the long evolutionary distance between these 
organisms) suggests that similar intron/exon structure may be a convergent 
adaptation related to a shared life history.  
In Oomycetes, the secretome (a collection of all secreted proteins coded by the 
genome) is a very active area of research due to the importance of these proteins in 
manipulating a host’s response to infection by these parasites. In our analysis, 2,908 
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proteins were identified as potentially secreted based on SignalP[6] detection of a 
signal peptide motif in the N-terminus of each protein (SignalP is a signal peptide 
domain detection program and was run within InterProScan as part of the InterPro 
domain analyses). While the presence of the signal peptide motif is not exclusive to 
secreted effector molecules, this list of proteins provides a potentially rich pool of 
candidates for future research into how Pythium ultimum interacts with its host 
during infection. 
Protein domain analyses also identified a number of Pythium ultimum DNA 
methylases. Interestingly, the Oomycete Phytophthora infestans lacks DNA 
methylase genes, the absence of which is believed to be responsible for repeat 
element expansion within that organism. Repeats make up more than 50% of the 
Phytophthora infestans genome[7]. By comparison, identified repeat elements make 
up only 7% of the Pythium ultimum genome. 
Annotation of BAC clones from the loblolly pine Pinus taeda 
Commonly known as the Loblolly Pine, Pinus taeda is a large coniferous tree 
native to the Southern United States. Because of the large size of the genome (~20-
30 gigabases), only a small sample of the genome had been cloned and sequenced at 
the time of our analysis (~1 megabases). I provided draft annotations and summary 
statistics for P. taeda using MAKER2. I also performed in-depth analysis of the 
repeat content of the sequence as an estimate for the genome as a whole. 
Because of the small amount of sequence available, I was unable to train 
gene-predictors such as SNAP for P. taeda. However, I was able to provide rough 
draft annotations by using a combination of monocot and dicot parameters from 
other plant species. In previous analyses, I have shown that evidence informed 
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MAKER2 annotations using incorrect species parameter files can achieve accuracies 
comparable to those of ab initio gene predictions using correct species parameters 
(See Table 2.3 in Chapter 2). In total, MAKER2 produced 18 gene models with an 
average length of 1,178 bp and 2.8 exons per gene under monocot parameters; 
similarly, MAKER2 produced 18 genes with an average length of 1401 bp and 2.9 
exons per gene under dicot parameters[8]. When scanned for InterPro domains, 12 
genes contained a known domain, or 67% of genes. However, incomplete protein 
homology alignments and a lack of consensus start codons suggest that many of 
these may be pseudogenes, which would not be unexpected in a genome this large 
(~20-30 gigabases). The presence of pseudo-genes could suggest a historical round of 
genome duplication or even polyploidy. However, previous analyses have found no 
evidence supporting whole-genome duplication[9]. 
Sequencing efforts in the P. taeda genome are still underway, and since the 
MAKER2 analysis of the genome, an additional ~11 megabases of high quality 
sequence has become available (providing ~12 megabases total). This is enough 
sequence to train the SNAP ab initio gene-predictor specifically for P. taeda. I 
explore annotation of this additional sequence in Chapter 5. 
MAKER2’s ability to annotate a selection of the P. taeda genome 
demonstrates the feasibility of annotating the entire ~20-30 gigabase genome 
sometime in the future. It also demonstrates the power of MAKER2 to extract useful 
information about gene structure, even when given extremely limited datasets for 
analysis. As more genome sequence becomes available, it will become possible to 
explore more definitively whether P. taeda has indeed undergone ancestral genome 
duplications as suggested by what appear to be an abundance of pseudogenes. 
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Annotation of the pitch canker fungus Fusarium circunatum 
Fusarium circunatum is a fungal pathogen of pine forests, with great 
ecological as well as economic significance to the forest industry. This genome 
project was one of a number of projects promoted by the South African government 
in part to help develop genomics and bioinformatics expertise in that country, and F. 
circunatum is the first eukaryotic genome to be sequenced in Africa. 
MAKER2 was used in this genome project to provide high-quality genome 
annotations. Because one of the primary goals of this project is the generation of 
bioinformatics expertise within South Africa, I also integrated MAKER2’s 
annotations into the GMOD community annotation system (CAS). In the CAS 
system, genome annotations are loaded into a Chado[10] database. Researchers then 
use the program Apollo[11] to access and edit all gene models live, via a remote 
connection. From there, researchers can either save back to the database or to a 
local GFF3 file. Saving to the database means all researchers involved in a genome 
project have instant access to the most up to date annotation set at all times, and 
changes made to a gene model are updated live for everyone. Using CAS, the F. 
circunatum community was able to provide at least some degree of manual curation 
to every gene in the genome, a major feat of human parallelization. 
The final MAKER2-plus-manual-curation dataset contained a total of 14,973 
genes, 67% of which contained known InterPro domains (based on InterProScan 
analysis). In comparison the fungal proteomes for Neurospora crassa, A. nidulans, 
and S. cerevisiae have InterPro domain enrichments of 62%, 73%, and 81%, 
respectively (Figure 3.2). The F. circunatum domain enrichment is therefore 
comparable to what is seen in other annotated fungal genomes. Further analysis of 
the F. circunatum genome is ongoing by the research community and will 
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undoubtedly provide important insights into the organism’s evolution as well as 
mechanisms it uses for pathogenesis. 
Annotation of the red harvester ant Pogonomyrmex barbatus 
Pogonomyrmex barbatus (the red harvester ant) is a species of ant found in 
the deserts of North America and is one of several ant species to be recently 
sequenced. Having a strict social order with biologically defined castes, study of P. 
barbatus could reveal important insights into the evolution of social behavior in 
these insects, including the pathways of gene expression underlying caste 
determination. With the additional sequencing of the related organisms Apis 
mellifera (honey bee)[12] and Nasonia vitripennis (wasp)[13], comparative analysis 
of the P. barbatus genome annotations could help elucidate the mechanisms of the 
adaptive radiation of Hymenoptera species (the order of insects that includes bees, 
wasps, and ants). 
MAKER2 was used to provide draft annotations for the P. barbatus genome. 
Gene annotations were then integrated into the GMOD community annotation 
system (CAS). This permits programs such as Apollo and GBrowse to remotely 
access a Chado database to rapidly distribute and curate the gene annotations live 
over the Internet, thus allowing for strong integration of the wider research 
community into the project. 
In total, the MAKER2-plus-manually-curation dataset contained 17,101 
genes (OGS 1.2), with more than 1,000 genes receiving some form of manual 
curation[30]. All final annotations were deposited in the Hymenoptera Genome 
Database[14] for distribution to the wider research community. The overall gene 
count for P. barbatus was similar to that of other published ant species (Solenopsis 
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invicta with 16,611 genes (v2.2.0)[31], Harpegnathos saltator with 18,564 genes 
(v3.3)[15], and Camponotus floridanus with 17,064 genes (v3.3)[15]. Quality control 
analysis showed InterPro domain enrichment of 53% in P. barbatus; this is also 
comparable to other published ant species (S. invicta with 53%, H. saltator with 
49%, and C. floridanus with 54%). The similarity of InterPro domain enrichments 
among all ant species reflects well on the quality of the P. barbatus genome 
annotations. 
Annotation of the Argentine ant Linepithema humile 
Linepithema humile (the Argentine ant) is a species of ant native to 
Argentina that has invaded regions in the United States and other countries on six 
continents (devastating many native species). Research into this organism is 
important for understanding not only its biology and evolution, but also possible 
mechanisms for controlling the expansion of L. humile. 
MAKER2 was used to annotate the L. humile genome in conjunction with 
manual curation and annotation using the GMOD community annotation system 
(CAS). In total, 16,049 gene models were produced for L. humile (OGS 1.2)[29] – a 
number comparable to that of other ant species (see results for P. barbatus 
annotation above). Additionally, 58% of annotations contained a known InterPro 
domain, which bodes well for annotation quality in this organism and is the highest 
domain enrichment among published ant species (see results for P. barbatus 
annotation above). 
The final genome annotations for L. humile are available through the 
Hymenoptera Genome Database[14]. The MAKER2 produced annotations for L. 
humile provide a resource not only for exploring questions such as the mechanisms 
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of sociality in ants, but also may provide ways to counter the ecological damage 
caused by this organism. 
Annotation of the leaf-cutter ant Atta cephalotes 
Atta cephalotes, more commonly referred to as the leaf-cutter ant, is a species 
of ant found in the rain forests of Latin America. They are known to harvest leaves 
that are then use to cultivate fungus. The fungus serves as the colony’s primary food 
source. This behavior is one of the few occurrences of farming exhibited outside of 
humans. Study of the A. cephalotes genome may reveal not only unique insights into 
the sociality of ants, but also into the effects of the selection imposed by obligate ant-
fungus mutualism on the evolution of this organism. 
The A. cephalotes genome was annotated using MAKER2 together with 
manual curation via the GMOD community annotation system (CAS). The final 
annotation set consisted of 18,062 gene models (OGS 1.2)[27], with 52% of genes 
containing at least one known InterPro domain. This domain content is similar to 
what is seen in other ant species – which range from 49-58% domain enrichment 
(see results above for P. barbatus and L. humile annotations). Gene annotations are 
publicly available through the Hymenoptera Genome Database[14]. 
Annotation of the sea lamprey Petromyzon marinus 
Petromyzon marinus is a species of lamprey, which is a jawless fish. 
Lampreys exist in mostly coastal and fresh waters. They are also found in, but are 
not native to, the Great Lakes. The invasion of the Great Lakes by these organisms 
has had both profound economic and ecological impacts on the region. Lampreys 
occupy an interesting position on the vertebrate evolutionary tree, just prior to the 
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evolution of the jaw. Analysis of the lamprey genome can therefore provide valuable 
insights into vertebrate evolution. Many characteristics of these organisms, such as 
their unique immune system (with parts unrelated to antibodies found in higher 
vertebrates)[16] and their ability to regenerate their spinal cord[17, 18], make them 
important subjects for continued research.  
MAKER2 was used to provide an initial set of draft annotations for P. 
marinus, whose genome is comparable in size to the human genome (the lamprey 
genome contains an estimated 2 gigabases of sequence). The genome assembly for P. 
marinus is relatively fragmented (consisting of ~25,000 super-contigs), which makes 
this organism a relatively difficult substrate for annotation. We supplemented 
MAKER2’s input evidence dataset with mRNA-seq to help offset the effects of 
genome fragmentation by increasing sensitivity for partial gene models. MAKER2 
produced an annotation set consisting of 24,132 gene models. This number of gene 
annotations is likely inflated relative to the true gene count for this organism; but 
this is to be expected given the fragmented nature of the genome assembly, as many 
genes are likely split across contigs. An analysis of InterPro domain content for 
quality control purposes showed a 54% enrichment for domain content in this 
organism, a percentage similar to what is seen in other eukaryotic genomes (see 
Figures 3.1 and 3.2) which bodes well for the confidence in the current annotation 
set (especially considering that many genes were likely too fragmented by assembly 
issues to recover entire domains). 
A major point of interest in studying the lamprey genome is the possible 
existence of whole-genome duplications in the lineage leading to lamprey as well as 
other vertebrates (commonly referred to as “the vertebrate two genome duplication 
hypothesis”)[19]. According to this hypothesis, a series of two or more genome 
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duplications occurred sometime early in vertebrate evolution and was one of the 
primary mechanisms for rapid expansion and diversification of vertebrate lineages. 
While there is evidence of these duplications in many vertebrate species, the timing 
of the duplication events is in dispute[20, 21]. The original proposal hypothesized 
that these duplications occurred in the stem leading to both lancelets and 
vertebrates; however, recent work suggests that these duplications may only have 
occurred in vertebrate lineages[22]. Analysis of the newly published amphioxus 
(lancelet) genome suggests that rounds of whole-genome duplication may have 
occurred both before and after the split between jawless vertebrates (i.e. lampreys) 
and jawed vertebrates[23]. The position of P. marinus on the evolutionary tree 
should allow researchers to address the question of whether duplication occurred 
before or after lamprey divergence by using both the genome sequence and its 
annotations. While the fragmented nature of the genome makes this type of analysis 
somewhat difficult (as synteny is not always apparent), the MAKER2 produced 
annotation database will provide a valuable resource to help address this and other 
questions (for example, preliminary results indicate the presence of two HOX 
clusters). Further analysis of this genome is ongoing by the lamprey research 
community.  
Maximizing annotation sensitivity in Schmidtea mediterranea 
Schmidtea mediterranea is a model system for the study of stem cells, 
regeneration, and tissue homeostasis[24, 25]. It is a protostome and a free-living 
species of Platyhelminthes (flatworms), an understudied yet evolutionarily 
important phylum. While flatworms are among the simplest bilaterally symmetric 
animals, they exhibit many features that make them important for research. They 
70 
 
are acoelomates yet they possess derivatives of all three germ layers organized into 
complex organ systems. They have one of the most primitive centralized nervous 
systems, and many species can regenerate complete individuals from only small 
fragments of tissue[26, 27]. Research of S. mediterranea benefits from the fact that 
these organisms are flat and nearly translucent, making them particularly easy to 
study in gene expression, gene knock-out, and gene knock-in type experiments (since 
effects in all organs and tissues can be directly visualized under a microscope 
without the need for dissection). Annotation of the S. mediterranea genome is 
providing researchers with the knowledgebase necessary to design these types of 
gene manipulation experiments, so we can better understand the mechanisms 
underlying regeneration and stem cell development in this organism.  
MAKER2 to was used to annotate the ~800 megabase S. mediterranea 
genome. The genome assembly for this organism was particularly fragmented, 
consisting of 43,295 contigs, the longest of which is just over 670,000 base pairs in 
length. The high level of fragmentation makes S. mediterranea, a particularly 
difficult substrate for genome annotation, and overall gene counts are expected to be 
inflated with many genes being be split across contigs. 
Because of the difficult nature of this genome, I had to explore new strategies 
to maximize MAKER2’s ability to identify partial and fragmented gene models. This 
was done primarily by integrated short mRNA-seq data into the MAKER2 analysis. 
The use of mRNA-seq data should increase the sensitivity of the MAKER2 pipeline 
as any assembly fragment containing even a piece of a gene should have significant 
overlap of mRNA-seq reads. Unfortunately this strategy also has the potential to 
decrease gene prediction specificity (i.e., increase gene over-prediction and false 
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positives), especially since repetitive sequence can create regions of false homology. 
Repeat identification is therefore given a great degree of priority in my analysis. 
An S. mediterranea specific repeat library was prepared by using the 
RepBase[28] repeat library together with the RepeatRunner[29] transposable 
element protein library to identify known repetitive elements. The program 
PILER[30] was then used to identify novel repeats specific to S. mediterranea. I 
classified the dataset of novel species-specific repeats based on comparison to 
conserved known repeats in RepBase (see Methods section below). This species-
specific dataset was then combined with the RepBase and RepeatRunner libraries to 
mask out all identified repetitive elements in the genome.  
Analysis of the repeats showed that the S. mediterranea genome is A/T rich, 
with low-complexity regions comprising 22% of all sequence, and high-complexity 
dispersed repeats comprising another 5.38%. The high-complexity repeats were 
largely composed of Helitrons, LINE, and viral sequences.  
Following preparation of a repeat library, short-read mRNA-seq alignments 
were processed using TopHat[31] and Cufflinks[32] and then passed to MAKER2, 
resulting in 38,924 gene models. Examination of the position of these gene models 
indicates that over 27,000 of these occur at the edge of contigs suggesting that as 
much as 70% of all annotations may be partial or split. When I looked at the 
InterPro domain content of these genes, a total of 53% contained known domains. 
The InterPro domain enrichment is comparable to what is seen in other eukaryotic 
genomes (Figures 3.1 and 3.2), which is surprising given that many genes appear to 
be partial and fragmented (partial models make it more difficult to capture enough 
sequence for domain identification). The domain enrichment thus provides a degree 
of confidence that the high gene count is not just the result of an abundance of false 
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positive gene predictions. The 53% InterPro domain enrichment seen in S. 
mediterranea is also comparable to the 54% seen in the similarly fragmented P. 
marinus genome. Overall domain content in both these organisms would be expected 
to improve with more genome sequence and assembly, making them excellent 
targets for future re-annotation (another analysis that is also facilitated by 
MAKER2). 
Of great interest to researchers studying S. mediterranea is its phylogenetic 
relationship to other organisms, including humans. Where exactly flatworms fit into 
the tree of life is still somewhat controversial. While Platyhelminthes are classified 
as protostomes, it is still debatable as to whether they belong to the Ecdysozoa (in 
general protostomes that molt their exoskeleton) or the Lophotrochozoa (most have a 
feeding appendage bearing hollow tentacles). Using the whole genome annotation 
set, I performed phylogenetic analysis in comparison to other eukaryotic genomes. 
The resulting phylogenetic tree firmly places S. mediterranea in the Lophotrochozoa 
with bootstrap support of 98/100 (Figure 3.4). 
Additionally, a comparison of total genes shared with other organisms 
(Figure 3.5) reveals that S. mediterranea shares more genes in common with human 
(5,390 genes) and mouse (5,467 genes) than it does with fellow protostomes C. 
elegans (4,411 genes) and D. melanogaster (4,617 genes) – both are Ecdysozoans. 
This data suggest that S. mediterranea in many ways is more like the ancestral 
Metazoan than certain other protostomes. These results are largely consistent with 
previous findings that gene loss has been one of the primary architects of metazoan 
evolution (with Ecdysozoans experiencing the greatest gene loss in comparison to 
deuterostomes and Lophotrochozoans)[33]. Because of the greater gene overlap with 
deuterostomes, S. mediterranea may in fact be a better model organism for studying 
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certain human biological processes than classic Ecdysozoan systems like C. elegans 
or D. melanogaster. All genome annotations, for S. mediterranea are available 
online at the SmedGD[34] online database. 
Conclusions 
The successful annotation of eight phylogenetically diverse emerging model 
organism genomes of varying genetic structure and assembly quality demonstrates 
MAKER2’s utility for producing database ready genome annotations for virtually 
any eukaryotic genome. The easy-to-use design of MAKER2 means it is especially 
suited for projects that may have limited resources and lack bioinformatics 
experience (e.g., the F. circunatum genome, a project to develop bioinformatics 
expertise in South Africa). The performance of the algorithm on the evolutionarily 
isolated Oomycete, Pythium ultimum, demonstrates MAKER2’s capability to 
annotate exotic/divergent genomes. The S. mediterranea and Petromyzon marinus 
projects highlight MAKER2’s ability to work on highly fragmented genomes, which 
are generally difficult substrates for annotation. Additionally, genome annotation of 
the Loblolly pine, Pinus taeda, where only ~1 megabase of sequence was initially 
available shows how MAKER2 can still produce usable, biologically relevant results 
even when available training data for ab initio gene-prediction is extremely limited 
or non-existent. The high-throughput parallelization capability of MAKER2 may 
also provide the only reasonable solution for future annotation of mega-genomes 
genomes like pine, which is greater than 20 gigabases in length. Finally, the ability 
to directly integrate MAKER2’s output into GMOD tools for downstream analysis 
has been shown time and time again to be extremely valuable. This is especially true 
of the GMOD community annotation system (CAS), which allowed our collaborators 
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on the Pogonomyrmex barbatus, L. humile, and A. cephalotes genome projects to 
directly access and edit MAKER2 annotations over the internet; thus better 
integrating the research community and producing a major feat of human 
parallelization to accelerate downstream analyses. In fact, the efficiency derived 
from integrating MAKER2’s output into this system allowed the ant genome projects 
to advance from annotation to manuscript submission in only 3 months, a 
monumental feat considering that these collaborative projects involved many 
researchers spread over several continents. 
Methods 
Pythium ultimum genome annotation 
MAKER2 was configured to use both spliced EST alignments as well as 
single-exon ESTs greater than 250 bp in length as evidence for producing evidence-
based gene predictions. MAKER2 was also set to filter out gene models for short and 
partial gene predictions that produce proteins with fewer than 28 amino acids. This 
value was selected because the smallest predicted protein in the related Oomycete 
Phytophthora infestans was 30 amino acids in length. The MAKER2 pipeline was 
set to produce ab initio gene predictions from both the repeat-masked and unmasked 
genomic sequence using SNAP[35] (trained using CEGMA[36]), FGENESH[37] 
(using existing Phytophthora parameter file), and GeneMark[38] (self-trained). 
The EST sequences used in the annotation process were derived from Sanger 
and 454 sequenced Pythium ultimum BR144 ESTs[39] considered together with 
ESTs from dbEST[40] for Aphanomyces cochlioides, Phytophthora brassicae, 
Phytophthora capsici, Phytophthora infestans, Phytophthora parasitica, 
Phytophthora sojae, and Pythium oligandrum. Protein evidence was derived from 
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the UniProt/Swiss-Prot[41, 42] protein database and from predicted proteins for 
Phytophthora infestans, Phytophthora ramorum, and Phytophthora sojae. MAKER2 
was also provided with a Pythium ultimum species-specific repeat library prepared 
for this work (created using PILER with no downstream classification). 
Both annotations and ab initio gene predictions not overlapping a MAKER2 
annotation were scanned for Pfam[43] and InterPro[44] protein domains using 
InterProScan[45]. All nonoverlapping predictions containing a domain were added to 
the annotation set. 
The MAKER2 produced gene annotation set was then submitted to the 
Pythium ultimum community for manual curation using the annotation editing tool, 
Apollo[11]. Manual annotations from Apollo were saved in GFF3[46] format and 
passed back through MAKER2 via the internal GFF3-passthrough option to both 
standardize the annotations and to calculate quality metrics for each gene model.  
Finally, putative functions were assigned to each annotated Pythium 
ultimum protein using BLASTP[47] to identify the best homologs from the 
UniProt/Swiss-Prot protein database. The functions of each best BLAST hit were 
then mapped to the corresponding Pythium ultimum protein. Individual researchers 
also assigned some putative protein functions during manual curation. 
Pinus taeda genome annotation 
The EST/cDNA sequences used by MAKER2 were derived from P. taeda as 
part of the sequencing project[8] and were combined with EST/cDNA sequences from 
all other Pinaceae species found in dbEST. The UniProt/Swiss-Prot protein database 
and all proteins from Arabidopsis thaliana[48] were used as the protein homology 
dataset for the MAKER2 run. Repeat elements were identified using MAKER2 
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default settings and pre-computed repeats from the program CENSOR[49] (passed 
to MAKER2 via the algorithms GFF3-passthrough option). 
MAKER2 was first run using the ab initio gene prediction algorithms SNAP, 
Augustus[50], and GeneMark (all trained for Arabidopsis thaliana) together with 
FGENESH (trained with generic dicot parameters). The second run of MAKER2 was 
performed using SNAP and GeneMark (both trained for Oryza sativa – rice) in 
conjunction with Augustus (trained for Zea mays – corn). Summary statistic for 
intron/exon structure and transcript lengths were calculated using the program 
Eval[51]. 
Fusarium circunatum genome annotation 
MAKER2 was configured with an EST set prepared for the genome project 
together with all F. circunatum ESTs available from dbEST. The protein homology 
set consisted of all proteins from the following genomes: Aspergillus niger, 
Batrachochytrium dendrobatidis, Candida albicans, Coccidioides immitis, 
Cryptococcus neoformans, Fusarium graminearum, Fusarium oxysporum, Fusarium 
verticillioides, Laccaria bicolor, Magnaporthe grisea, Monosiga brevicollis, Nectria 
haematococca, Neurospora crassa, Phycomyces blakesleeanus, Pichia stipitis, 
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Sclerotinia sclerotiorum, 
Sporobolomyces roseus, Stagonospora nodorum, Trichoderma atroviride, 
Trichoderma reesei, Trichoderma virens, and Ustilago maydis. These proteins were 
combined with the UniProt/Swiss-Prot database, and all Fusarium proteins in 
GenBank[52]. Repeat masking options were set to default values in MAKER2. 
Annotations and nonoverlapping gene predictions were scanned for InterPro and 
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Pfam domains using InterProScan, and all nonoverlapping predictions with a 
domain were added to the final annotation set. 
Resulting annotations were loaded into a Chado[10] database and then 
accessed using Apollo. Some contigs were saved back to GFF3 format, in which case 
they were merged back into the formal annotation dataset by running MAKER2 
with the model_gff options set to the location of the manually curated GFF3 file. 
Pogonomyrmex barbatus genome annotation 
MAKER2 was provided with a species-specific repeat library consisting of 
novel repeats identified by RepeatModeler[53] and PILER[30] in both the P. 
barbatus and L. humile genomes. For the protein evidence, proteins from the 
UniProt/Swiss-Prot database, D. melanogaster, A. mellifera, N. vitripennis, and 
insect chemosensory proteins from GenBank were combined into a single dataset. 
The P. barbatus EST dataset consisted of ESTs sequenced as part of the genome 
project together with Hymenopteran and L. humile ESTs from dbEST. 
Prior to running MAKER2, we independently trained the ab initio predictors 
SNAP (trained with CEGMA), Augustus (trained with packaged training script 
autoAug.pl), and GeneMark (self-training).  
Following automatic annotation, we ran InterProScan over the set of 
MAKER2 annotations as well as ab initio gene predictions that did not overlap a 
MAKER2 annotation. Nonoverlapping gene predictions that contained a domain 
were then added to the final annotation set. The MAKER2-generated annotations 
were also subjected to further human review and curation (see ‘Community 
Annotation System’ below). 
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Linepithema humile genome annotation 
The L. humile EST dataset consisted of ESTs sequenced as part of the 
genome project together with all Hymenopteran and L. humile ESTs from dbEST. 
For the protein evidence, the UniProt/Swiss-Prot database, D. melanogaster, A. 
mellifera, N. vitripennis, and insect chemosensory proteins from GenBank were 
combined.  
Prior to running MAKER2, we independently trained the ab initio predictors 
SNAP (trained using CEGMA), Augustus (trained with the packaged autoAug.pl 
script), and GeneMark (self-trained). MAKER2 was also provided with a species-
specific repeat library consisting of novel repeats identified by RepeatModeler and 
PILER in both the P. barbatus and L. humile genomes. 
Following automatic annotation, we ran InterProScan over the set of 
MAKER2 annotations as well as the set of non-overlapping ab initio gene predictions 
(do not overlap an annotation). Nonoverlapping gene predictions that contained a 
domain were added to the final annotation set. The MAKER2-generated annotations 
were then subjected to further human review and curation (see ‘Community 
Annotation System’ below). 
Atta cephalotes genome annotation 
The EST dataset for A. cephalotes consisted of an EST dataset sequenced 
specifically for that genome together with Hymenopteran and A. cephalotes ESTs 
from dbEST. The protein dataset was identical to that used for P. barbatus and L. 
humile annotation, as was the repeat library. Prior to running MAKER2, we trained 
the ab initio predictors SNAP (used CEGMA training), Augustus (trained with the 
packaged autoAug.pl script), and GeneMark (self-trained).  
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Following automatic annotation, we ran InterProScan over the set of 
MAKER2 annotations as well as the set of non-overlapping ab initio gene 
predictions. Nonoverlapping gene predictions that contained a domain were added to 
the final annotation set. The MAKER2-generated annotations were then subjected 
to further human review and curation (see ‘Community Annotation System’ below). 
Petromyzon marinus genome annotation 
Inputs for MAKER2 included the P. marinus genome assembly, P. marinus 
ESTs sequenced for this project, and a protein databases containing all annotated 
proteins for human, mouse, chicken, D. melanogaster, C. elegans, Xenopus 
tropicalis, Strongylocentrotus purpuratus (sea urchin), Branchiostoma floridae 
(lancelet), Lottia gigantea (sea snail), Ciona intestinalis (sea squirt), Trichoplax 
adhaerens, Nematostella vectensis (sea anemone), Danio rerio (zebra fish), and 
Takifugu rubripes (puffer fish) combined with the UniProt/Swiss-Prot protein 
database and all sequences for Chondrichthyes (cartilaginous fish) and Myxinidae 
(hagfishes) in the NCBI protein database. Ab initio gene predictions were produced 
inside of MAKER2 by the programs SNAP and Augustus. MAKER2 was also passed 
P. marinus mRNA-seq data processed by the programs TopHat[31] and 
Cufflinks[54]. MAKER2 was run in a bootstrap-fashion, with the output gene models 
of one run acting as inputs for retraining ab initio gene-predictors, thus better 
informing mRNA-seq alignment junctions for TopHat and Cufflinks. A total of three 
iterative runs of MAKER2 were performed. 
Following genome annotation, gene models were analyzed using the program 
InterProScan to identify putative Pfam and InterPro protein domains. Ab initio gene 
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predictions that did not overlap a MAKER2 annotation but contained a domain were 
added to the annotation set. 
The GMOD Community Annotation System (CAS) 
All gene annotations and supporting evidence alignments produced by 
MAKER2 (as well as protein domain information derived from InterProScan) were 
loaded into a Chado database to facilitate community access. The annotation 
curation tool Apollo was then used to allow researchers to view and manually edit 
the genome annotations in the database. Apollo allows users to connect remotely to 
the Chado database over the Internet, thus providing a way for researchers to curate 
the genome annotations from distinct locations. Apollo was configured as a Java 
Web Start application, which can be pre-configured and pushed onto a computer via 
a web-browser. This kept configuration of the program under the control of a central 
server and ensured consistency in the way data could be viewed and accessed. 
Schmidtea mediterranea genome annotation 
The annotation pipeline MAKER2 was used to annotate the S. mediterranea 
genome. The algorithm identifies repetitive elements, aligns ESTs and protein 
homology to the genome, integrates pre-processed mRNA-seq alignments, produces 
ab initio gene predictions, and integrates these data to synthesize downstream 
genome annotations. 
The EST dataset used consisted of ESTs sequenced for the S. mediterranea 
genome project[34, 55]. The protein homology set consisted of all proteins in the 
UniProt/Swiss-Prot protein database, all Schistosoma mansoni proteins from 
Sanger, and all GenBank proteins for Nematostella vectensis, H. sapiens, C. 
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elegans, and S. mediterranea. Unpublished short read mRNA-seq transcriptome 
datasets prepared for the genome project were processed with the programs TopHat 
and Cufflinks. The scripts tophat2gff3 and cufflinks2gff3 (both included with 
MAKER2) were used to process the results into GFF3 format. The resulting GFF3 
files were provided to the est_gff option in MAKER2. A species-specific repeat 
library prepared for S. mediterranea was also supplied to MAKER2. 
Prior to running MAKER2, the predictor SNAP was trained using CEGMA to 
generate an initial training set of conserved universal eukaryotic genes. After 
running MAKER2, SNAP was re-trained using the resulting first round MAKER2 
genome annotations identified as high quality via the script maker2zff (which is 
included with the MAKER2 distribution). Augustus was also trained using this 
same first round MAKER2 training set. MAKER2 was then run one last time using 
the updated training files to produce final annotations. 
InterProScan was used to identify InterPro and Pfam domains for all 
resulting S. mediterranea annotations as well as nonoverlapping ab initio gene 
predictions. Any nonoverlapping prediction containing a know domain was added to 
the final annotation set. 
Schmidtea mediterranea repeat library preparation 
We used RepeatMasker together with the RepBase library of repetitive 
elements to identify repeats in the S. mediterranea genome. The program PILER 
was used to identify novel repeats not identified by RepeatMasker. 
To classify these novel repeats, we used BLAST to locate (via BLAST score) 
the five best hits for each repeat element within the unmasked S. mediterranea 
genome. Each of the five best hits was then extended 500 bp upstream and 
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downstream. The resulting extended repeat sequences served as queries for 
searching the RepBase library via BLASTN. This was done because many novel 
repeats may just be divergent extensions of repeats already found in RepBase. 
RepBase also served as a query against itself in BLASTN to identify homology 
within the database between repeats. 
All BLAST hits found in these analyses were clustered and compared via 
single-linkage clustering. Linkage was determined by two hits sharing an e-value 
above a given threshold. Consensus classification was then made by looking for 
statistically significant overrepresentation of RepBase repeat-families as identified 
by chi-squared analysis with a p value of 0.001. The linkage threshold was gradually 
relaxed to create the maximally large cluster with statistically significant RepBase 
association. The threshold initially started at 1x10-304 and was gradually relaxed to 
1x10-4. Once repeats were clustered, each cluster was classified or named based on 
the most common repeat type within that cluster. 
Schmidtea mediterranea orthology comparison 
To determine how orthology of S. mediterranea genes compares to what is 
seen in other model systems, we performed an all-by-all BLASTP analysis of H. 
sapiens, C. elegans, D. melanogaster, M. musculus, N. vectensis, C. intestinalis, S. 
purpuratus, and S. mediterranea. We then estimated the number of orthologs 
between each genome using reciprocal-best-hits analysis (wherein, if the best hit of 




Schmidtea mediterranea phylogenetic tree construction 
To perform phylogenetic analysis of the S. mediterranea genome, we first 
identified a subset of conserved genes that could be used to produce a concatenated 
multi-gene alignment. This was done by performing an all-by-all BLASTP analysis 
using the following genomes: X. tropicalis, T. rubripes, H. sapiens, S. mansoni, 
Schistosoma japonicum, D. melanogaster, C. elegans, N. vectensis, Ciona 
intestinalis, L. gigantea, Capitella teleta, Tribolium castaneum, Tricoplax adherens, 
S. purpuratus, S. cerevisiae, and Monosiga brevicollis. WUBLAST[56] BLASTP was 
configured with the following parameters: E=0.001, matrix=BLOSUM45, Q=14, R=2, 
gapK=0.032, gapL=0.195, gapH=0.10, gspmax=10, hspmax=10, and wordmask=seg. 
Reciprocal-best-hits analysis was then used to identify orthologs across species. Only 
genes that contained orthologs for all 16 species were kept (i.e., conserved in all 
species). The sequence for each gene was concatenated for every species (the 
transcript with the best alignment to human was used in cases where multiple 
transcripts existed). The concatenated sequences were then aligned using 
ClustalW[57] and processed by GBlocks[58] to identify conserved blocks of homology. 
The concatenated alignment was then processed into 100 bootstrap datasets using 
the Phylip[59] program SEQBOOT, and tree topology was produced for each dataset 
using Phylobayes[60] (CAT model). Phylobayes was run to 500 generations with the 
first 100 trees of each run being discarded as ‘burn in’ (in accordance with 
Phylobayes documentation). Phylobayes generated a consensus tree for each dataset 
using the remaining 400 generations. The Phylip program Consense was then used 
to obtain the bootstrap consensus tree from the 100 datasets, and the Phylip 
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Figure 3.1 Comparison of domain content in Oomycetes. 
The percentage of genes containing a known InterPro protein domain is persistent 
across all species of Oomycetes. These similarities extend to the functional makeup 
of these genomes as well (as seen using GO terms associations for molecular 
function). The consistency of patterns in Pythium ultimum in comparison to 
Phytophthora species suggest there is no obvious systematic functional bias inherent 
from the gene annotation process, and that the quality of the MAKER2 gene 



































































































































Figure 3.2 Domain content in reference eukaryotes. 
The overall similarity in the functional makeup of eukaryotic genomes is clear from 
a visual comparison of the GO function pie charts. This relatively invariant pattern 
of domain content and GO term distribution makes it simple to derive expected 
patterns of genome functional makeup for virtually any eukaryotic organism. 
Deviation from this pattern would indicate problems with genome annotation. These 
genome have slightly higher InterPro domain content than Oomycetes do, which is 
less indicative of differences in biology for these organism, and more related to the 
fact that Oomycetes are evolutionarily distant from most sequenced eukaryotes 
(some Oomycete genes may contain new or divergent protein domains that would 















































































































































Figure 3.3 Comparison of intron/exon structure across eukaryotes. 
Many genes in Pythium ultimum are large single exon genes. However, orthologs of 
these single exon genes in other eukaryotic organisms tend to be intron rich, 
suggesting a possible evolutionary trend in P. ultimum for intron loss. The example 
in the figure shows orthologs of the gene midasin, which encodes a highly conserved 
~600 kDa nuclear chaperone protein. Orthologs in both Mus musculus and 
Arabidopsis thaliana are intron rich; however, orthologs in Saccharomyces 
cerevisiae and P. ultimum are both encoded by a large single exon. The similarity in 
gene structure between S. cerevisiae and P. ultimum is surprising given the 
evolutionary distance between these organisms (Oomycetes are equidistant from 
plants, animals, and fungi) and suggests that intron loss may be a convergent 

















Figure 3.4 Phylogenetic analysis of Schmidtea mediterranea .  
Whole genome phylogenetic analysis of sixteen eukaryotes using Bayesian methods 
firmly places Schmidtea mediterranea in the Lophotrochozoa, with a high bootstrap 
score of 98/100. Two related species of parasitic flatworms fall into in the same 
grouping (further supporting this classification). The relatively long branch lengths 
for the three Platyhelminthes species suggest that these organisms may have 
















































Figure 3.5. Genes shared by Schmidtea mediterranea  with other metazoans. 
The level of orthology for Schmidtea mediterranea is similar to what is seen between 
other metazoans, which reflects well on the quality of the gene models (considering 
the high level of assembly fragmentation). We see that on average S. mediterranea 
shares more genes with deuterostomes and cnidarians than it does with more closely 
related protostomes (Drosophila melanogaster and Caenorhabditis elegans). The S. 
mediterranea genome may therefore be basal in nature (i.e. having more in common 









    
CHAPTER 4 
EDUCATIONAL OUTREACH 
While second-generation technologies are making genome and transcriptome 
sequencing routine even for small laboratories, the large volumes of data they 
produce are overwhelming many research groups with issues of data management 
and downstream analysis. This is especially true for smaller groups with limited 
bioinformatics expertise. While we have developed MAKER2, a tool for automated 
genome annotation and database management, overhead related to the installation 
of prerequisite software as well as the fact that MAKER2 is a command line tool 
may intimidate many researchers (especially if they have no experience navigating a 
Linux environment). To help overcome these issues, we have made a concerted effort 
through educational outreach to train the scientific community in strategies for 
genome annotation as well as in the use of Generic Model Organism Database 
project (GMOD)[1] tools like MAKER2. 
As part of our effort to educate the scientific community in strategies for 
genome annotation, MAKER2 classes and workshops have been taught at several 
international meetings and conferences. MAKER2 was the opening workshop for the 
GMOD Summer School of the Americas in 2009 and 2010; and at the 2009 GMOD 
summer school, MAKER2 received the highest marks of any workshop. MAKER2 
was also presented as a course at the 2011 GMOD spring training session at 
95 
 
NESCent. At the Plant and Animal Genome Conference, MAKER2 workshops were 
presented in 2010 and 2011, and a MAKER2 workshop was taught at the 2010 
Arthropod Genomics Symposium.  
 There have also been a number of independent workshops on using 
MAKER2 presented as part of bioinformatics courses: the University of Maryland 
(Brandi Cantarel), Texas A&M University (Jim Hu and Rodolfo Aramayo), and the 
University of Utah (Karen Eilbeck). Additionally, Christopher Smith at San 
Francisco State University used MAKER2 and Apollo[2] as hybrid teaching/research 
tools to finish up genome annotations for the Pogonomyrmex barbatus[3], 
Linepithema humile[4], and Atta cephalotes[5] genome projects. Similarly, 
researchers at the 2010 Fusarium Circunatum genome annotation jamboree held at 
the University of Pretoria in South Africa were trained in using MAKER2 and 
Apollo as part of an effort to develop bioinformatics expertise in that nation. 
Through my work on MAKER2, I have also become an advisor for DNA Subway[6], a 
tool produced by Cold Spring Harbor Laboratory’s Dolan DNA Learning Center to 
introduce high school and undergraduate students to genome annotation. 
While efforts in educational outreach have made major inroads in the 
scientific community, the development and distribution of web-based annotation and 
analysis tools could even-further increase the availability of MAKER2 as well as 
provide educational opportunities to a wider array of scientists. In this effort, I have 
developed the MAKER Web Annotation Service, which makes genome annotation 
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MAKER WEB ANNOTATION SERVICE: AN 
ONLINE PORTAL FOR GENOME 
 ANNOTATION AND ANALYSIS 
Abstract 
I have developed the MAKER Web Annotation Service (MWAS), a web-based, 
distributed multiuser environment that permits automated genome annotation and 
downstream analysis via a simple web-browser. MWAS serves as a portal to 
annotate genomic datasets for users lacking sufficient bioinformatics expertise (or 
computer resources) to install, configure, and run the command-line program 
MAKER2. MWAS is also an online educational tool where users can explore 
strategies for genome annotation and analysis using applications from the Generic 
Model Organism Database project (GMOD)[1], the European Bioinformatics 
Institute (EBI), and the Sequence Ontology project[2]. 
Rationale 
The challenges of modern genomics extend beyond merely annotating 
genomes, as annotations must also be subjected to diverse and complex downstream 
analyses. To this end, I have developed the MAKER Web Annotation Service 
(MWAS), in which I have integrated the MAKER2 genome annotation pipeline 
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together with other downstream applications and GMOD tools. MWAS acts as a 
portal for biological research by providing annotations and downstream analyses for 
submitted genomic sequences. MWAS is also an educational tool, allowing 
researchers to explore strategies for genome annotation as well as methods for 
integrating annotations into external applications (all just by typing a URL into a 
web-browser). Through the web-based environment, users can annotate genome 
sequences, identify protein domains, annotate putative gene functions, and add 
associated Gene Ontology (GO)[3] terms to annotations. All results are 
automatically incorporated into GMOD and Sequence Ontology tools. Thus, MWAS 
provides a unified web-based resource for easy genome annotation, distribution of 
results, and global analyses of annotation features. MWAS also permits concurrent 
viewing of annotations via GBrowse[4] and JBrowse[5] (online annotation 
visualization tools), and remote manual editing of annotations using Apollo[6] (an 
annotation curation tool). This seamless integration with external tools greatly 
increases the efficiency of small project collaboration by enabling researchers in 
different locations to edit and analyze a shared genome dataset remotely.  
Algorithm/website design 
Development of a web-based annotation and analysis tool imposes several 
design constraints. Because of the large datasets involved in genomics as well as the 
potential confidential nature of those datasets, researchers need to reuse the same 
files without having to upload them multiple times, and at the same time, they want 
to restrict access to their experimental data and results. Both of these requirements 
are met by having individual accounts with a password-protected login. However, 
because casual users and those using MWAS solely for educational purposes may be 
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intimidated by a registration and login requirement, these are optional. Depending 
on the size of datasets submitted, annotation can take anywhere from a few minutes 
to several hours. Therefore, users need a way to submit an analysis to MWAS and 
return at a later time once it has completed. While this requirement is easily met for 
datasets linked to a password-protected account, providing return access to 
anonymous users must be met by a different mechanism and is achieved via links 
that can be copied and bookmarked by the user. These links will automatically 
return the web-browser to the correct datasets and results. 
While genome annotations provide a starting point for genomics-based 
research, they are not an end in themselves. After annotating a genome, researchers 
also need to carry out downstream analyses; these analyses include finding protein 
domains, adding GO terms to annotations, identifying orthologs in related species, 
and elucidating potential gene functions. Additionally, researchers need global 
statistics that can be compared between organisms, such as gene count, average 
intron length, etc. But most importantly, researchers want to visualize the data so 
they can better interpret the results. While there are numerous software tools that 
can perform these tasks, requiring users to install and configure these tools before 
using MWAS would produce a barrier inconsistent with the easy-to-use aspects of 
the service. To meet these downstream analysis needs as well as to provide proof-of-
principle examples for educational users, I have integrated software tools from 
GMOD, the EBI, and the Sequence Ontology project into MWAS.  
Entering MWAS 
When a user first enters the MWAS website, they are presented with a login 
page that lets them access an existing account, register as a new user, or access the 
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site anonymously as a guest (Figure 5.1). Once inside of MWAS, the user is 
presented with the main page for the website, which shows the results of finished 
analyses as well as the status of unfinished jobs that were submitted by the user. At 
the top of the main page, there is a series of tabs for navigation of the website. These 
tabs allow the user to submit new datasets for annotation, manage/upload analysis 
files, or seek help via e-mail and written documentation. 
Submitting datasets and configuring MWAS for annotation 
To submit datasets for analysis, users must first upload genome sequence 
and any desired analysis support files to MWAS. This is done by selecting the 
‘Manage Files’ tab at the top of the main page. From there, users can submit 
genomic sequence for annotation as well as EST and protein homology datasets for 
alignment against the genome. If users have trained ab initio gene-predictors such 
as SNAP[7] or GeneMark[8], they can also submit species parameter files for those 
programs. Additionally, if users have datasets of pre-existing ab initio gene 
predictions or legacy annotations, and they wish to use them for re-annotation of a 
genome, these files can be submitted in GFF3[9] format. 
When users are ready to annotate an uploaded genome, they must select the 
‘New Job’ tab at the top of the screen. From there, users customize the MWAS 
annotation engine (MAKER2) via a series of dropdown menus. Using these menus 
the user selects the genome file to be annotated as well as a set of ESTs and a 
protein homology evidence to align against the genome (Figure 5.2). Advanced 
options for repeat masking and the ab initio gene prediction are configured here as 
well. Alternatively, users who are using MWAS for educational purposes can select 
from a list of preconfigured example annotation jobs. When finished selecting all 
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desired parameters, users submit their job to the annotation queue where MAKER2 
will process it. 
Viewing and downloading annotation results 
After submitting a new job, the status of that job is displayed on the MWAS 
main page. Each submitted job has an associated ‘JobID’ that can be used to review 
the previously supplied MAKER2 configuration parameters. There is also a ‘Log’ 
that displays any problems encountered by MAKER2 during its analysis. Upon 
completion of a submitted annotation job, a new icon appears that allows users to 
access resulting gene annotations. From there, users can simply download results to 
their own computer for further analysis, or they can view the annotations using 
integrated GMOD tools. If the user selects ‘View in GBrowse’ or ‘View in JBrowse’, 
the annotations are immediately displayed in a separate window using those 
programs. By using viewing programs like these, annotation structure can be 
verified and evaluated in relation to aligned evidence from ESTs and protein 
homology, and users can decide whether to accept the annotations or make changes 
to MAKER2’s configuration parameters for job resubmission. By clicking on ‘View in 
Apollo’ in the results menu (Figure 5.3), users have the option to manually edit gene 
structure using a preconfigured Java Web Start version of Apollo that will 
automatically be pushed over the Internet and installed on their machine. Any 




Postprocessing of gene annotations 
While MAKER2-produced structural annotations comprise a valuable 
resource, researchers also have needs for other types of downstream analyses. 
MWAS provide users with access to external tools that can perform those tasks. To 
have access to summary statistics for genome annotations, the user can select ‘SOBA 
Statistics’ from the results menu (Figure 5.4). This will upload MAKER2-produced 
annotations to SOBA[10], a summary statistics tool from the Sequence Ontology. 
From there, users can explore statistics on gene numbers, exon structure, coding 
sequence and transcript length, intron density, and many other useful summary 
values. Users can also view the Sequence Ontology relationships between different 
annotated features in the genome and produce reports that can be downloaded back 
to a local computer. 
If a user is satisfied with MAKER2-produced annotations based on manual 
inspection of gene models in GBrowse, JBrowse, and Apollo, he/she can then submit 
annotations to downstream functional analyses by selecting ‘Do postprocessing of 
annotations’ from the results menu. From there, users have the option to add 
putative gene functions via comparison to the UniProt/Swiss-Prot[11, 12] protein 
database or to identify InterPro[13] domains and associated GO terms using the 
program InterProScan[14]. Users can also rename genes to comply with NCBI 
suggested naming formats using a registered genome project prefix. Additionally, if 
the user does not yet have a trained ab initio parameter file for the organism being 
analyzed then MWAS can attempt to train the gene-predictor SNAP for them.  
After selecting and submitting desired postannotation analyses, a new job 
will appear on the MWAS main screen. Just as with the earlier MAKER2 analysis, 
each submitted job has an associated ‘JobID’ that can be used to review the 
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configuration parameters and a ‘Log’ that displays any problems encountered curing 
postprocessing. 
Upon completion, users can access the results via a new icon that appears 
next to the job. The postannotation analysis results menu is nearly identical to the 
MAKER2 results menu, and users can still view datasets in GBrowse, JBrowse, and 
Apollo or download the data locally for further experimentation. However, when 
results are loaded into GBrowse, you will see that the annotations have changed 
relative to the earlier MAKER2-produced results. With all postanalyses options 
selected, gene names will now be updated to use the user-supplied prefix followed by 
a unique identifier, and putative gene functions will be displayed below each gene 
model (Figure 5.5). Additionally, in the GBrowse track options, ‘InterPro Protein 
Domains’ will appear as an option, and when selected, it will display protein 
domains as physical feature aligned against the genome. When users click on one of 
the gene models shown in GBrowse, a new page will be displayed containing all 
information for that gene including integrated protein domains, associated GO 
terms, putative gene functions, and any MAKER2-produced quality control statistics 
(Figure 5.6). By providing and incorporating these data automatically into the 
annotations, MWAS allows users to more quickly and efficiently transition to 
downstream comparative analyses and experimentation using the genome 
annotations as substrates. 
Annotation of Pinus taeda BAC clones 
As a proof-of-principle example of the performance of MWAS, I used it to 
annotate a set of 111 contigs assembled from the sequencing of Pinus taeda BAC 
clones (~12 megabases of total sequence). The entire ~20-30 gigabase P. taeda 
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genome has yet to be fully sequenced, and these contigs exemplify the type of 
smaller dataset that might be submitted to MWAS. In general these are datasets 
that are not large enough to justify the installation of the entire MAKER2 
annotation pipeline, but they are still rich enough to provide a valuable resource for 
further study of an organism. Results from the P. taeda BAC clone contigs can 
potentially serve as a test dataset for future annotation of the entire genome; and 
many groups are using them as preliminary results for justification of genome 
sequencing proposals. I also performed postprocessing analyses of the annotations to 
identify protein domains, GO term associations, putative gene functions, and to 
provide a trained SNAP parameter file for P. taeda. 
Using this set of 111 contigs assembled from the sequencing of Pinus taeda 
BAC clones (~12 megabases of total sequence), MWAS identified 220 genes, of which 
64% contained known InterPro domains. In comparison Arabidopsis thaliana, a very 
well annotated reference genome, has a domain enrichment of 79%. The similarity in 
domain content between these organisms reflects well on the quality of the MWAS 
produced annotations, especially given the extremely limited nature of the P. taeda 
dataset. 
When I further analyze the annotations via SOBA (a summary statistic tool), 
I see that the average gene contained 2.6 exons, the average coding length of each 
gene was 572 bp, and coding regions make up < 1% of the total DNA sequence. 
These kinds of summary statistics provide the foundation researchers need for 
comparing genes from a newly sequenced genome to those of other related 
organisms. The summary statistics and annotation functional data also provide a 
basis for analyzing the quality of the gene annotations. But what is amazing about 
these data is the fact that they were conveniently and automatically generated via a 
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simple web-browser. There was no complex data manipulation required from the 
user, instead pointing and clicking was sufficient. 
While our simple exercise with using P. taeda BAC sequence demonstrates 
the ease of genome annotation and analysis using MWAS, I was also able to extract 
much useful information that could be applied to any future pine genome project. 
For example, the basic statistics for patterns of gene structure (produced by SOBA) 
and the SNAP training file produced by MWAS, all provide the kind of high-quality 
reference data that can help jumpstart a genome project, primarily by eliminating 
the need to pre-train ab initio gene predictors. 
Conclusions 
MWAS serves as a powerful tool that can provide detailed structural and 
functional annotations from genomic datasets. The easy-to-use interface makes 
genome annotation as simple as entering a URL and provides a convenient 
mechanism for visualizing annotations and distributing them to collaborators. By 
further leveraging the power of tools from GMOD, the EBI, and the Sequence 
Ontology, MWAS provides an efficient pathway to downstream analyses. The P. 
taeda genome sequence serves as a proof-of-principle example of how groups can use 
this tool in their own research. Also, the simple web-based interface and supplied 
example datasets make it easy for anyone to use MWAS as an educational tool for 




Availability and requirements 
MWAS can be accessed through the Yandell Lab website at 
http://www.yandell-lab.org. It requires nothing more than a web-browser with 
JavaScript enabled. MWAS can also be installed locally on machines running Linux, 
Mac OS X, or other Unix-like operating systems, and it is bundled into the standard 
MAKER2 software package (versions 2.11 and greater). For local installation of 
MWAS, the Apache web server is required as well as GBrowse (2.10 or greater), 
JBrowse (1.2 or greater), Apollo (1.11.6 or greater), and InterProScan (4.X) in 
addition to all standard MAKER2 prerequisites. 
Methods 
P. taeda BAC sequence was obtained from GenBank[15] and uploaded to 
MWAS together with an EST dataset consisting of all P. taeda and Pinaceae ESTs 
found in dbEST[16]. The set of all Viridiplantae proteins from GenBank served as 
the input protein homology dataset. 
An annotation job for P. taeda sequence was first submitted using the 
est2genome prediction option, which produces gene models directly from EST 
alignments. This was done because no pine specific ab initio prediction parameters 
were yet available. The est2genome set of annotations was used as the basis for 
SNAP training during later postprocessing in MWAS. Once SNAP was trained, the 
annotation job was resubmitted using the newly trained parameter file. The 
resulting MWAS-SNAP annotation set was then submitted to another round of post-
processing to identify protein domains and putative gene functions. Gene names 
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Figure 5.1 MWAS login screen. 
MWAS uses a password-protected login to secure users’ experimental data as well as 











Figure 5.2 The MWAS job submission screen. 
MWAS allows users to configure MAKER2 just as they would on the command line 












Figure 5.3 View of MWAS annotations in Apollo. 
Once an annotation job is complete, the user has many viewing and analysis options 
that can be accessed directly from the website. In this screen shot, we see how Apollo 
has been launched by MWAS with the correct dataset already loaded and configured 
for the user.  DNA sequence runs from left to right, gene annotations are shown in 











Figure 5.4 Annotation summary statistics. 
MWAS can provide users with basic statistics for the genome annotations by using 
the tool SOBA from the Sequence Ontology project. In this screen shot, we are 
looking at the length distribution of coding sequence (CDS features) in the genome. 
SOBA can also produce written reports of annotation statistics that can be 
downloaded locally for further analysis. MWAS lets the user launch SOBA from the 













Figure 5.5 View of MWAS functional annotation integration. 
In addition to MAKER2 provided structural annotations, users can perform 
downstream analyses in MWAS to identify protein domains, putative gene functions, 
and gene associated GO terms. Users can also reformat gene names to correspond to 
registered genome project prefixes. In this screen shot, we see gene models and 
downstream functional annotations identified and loaded into GBrowse by MWAS. 
Note that gene models (in blue) have been named with the prefix ‘GMOD’, and the 
putative gene function is displayed below each gene annotation. MWAS also 
identified InterPro domains in the genes and displays them as physical features 





Figure 5.6 Association of results and analyses with gene annotations. 
MWAS is able to associate a wide body of information to each gene as part of its 
analyses. By clicking on a gene model in GBrowse, the user is taken to a summary 
page (shown in this screen shot) that displays all information available for that gene 
including: protein domain content, associated GO terms, putative gene functions, all 
MAKER2 produced quality control statistics, and many other useful types of 
information. The ability of MWAS to rapidly collect these data and make them 
available to the user demonstrates the power of MWAS. This same data is also 












MAKER2 is a genome annotation pipeline designed for research groups with 
little bioinformatics experience. The program identifies and collects evidence for 
building gene annotations using EST and protein alignments, third-party gene 
prediction programs, and other evidence as supplied by the user. Using these input 
datasets, MAKER2 produces a final set of database-ready gene annotations in 
GFF3[1] format. 
The basic strategy behind MAKER2 is to automatically take a sequence from 
a genome assembly and guide that sequence through a series of evidence collection 
steps. The genome sequence is passed from one external executable to another, and 
results are collected and interpreted by MAKER2. At the end of this process, 
MAKER2 uses the collected evidence to supply hints about the locations of introns, 
exons, and protein coding regions to ab initio gene-prediction algorithms. The hints 
provided by MAKER2 increase the accuracy of the final gene models. Gene models 
are also tagged with codes that identify the types and quantity of evidence 
overlapping them. These tagged gene models are then saved together with their 
associated evidence trails as final database-ready gene annotations. 
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Supported system architectures 
MAKER2 is designed to support laptop and desktop machines running Unix-
like operating systems (i.e., Linux or Mac OS X). These are machines likely to be 
found in the average research laboratory. However, MAKER2 is also compatible 
with the distributed system architectures found in advanced computer clusters. 
MAKER2 can therefore be run on systems as simple as a laptop or as complex as a 
computer cluster with thousands of processors. 
Input to MAKER2 
MAKER2 accepts input files in FASTA and GFF3 formats. At the very least, 
a user is expected to supply MAKER2 with a genome sequence file, an EST dataset, 
and a protein homology dataset. Datasets in FASTA format will be aligned and 
processed by MAKER2, while datasets in GFF3 format (which contain pre-aligned 
features) will bypass many of theses computational steps. 
Because of the large number of potential annotation parameters and input 
files, it would be inconvenient to configure MAKER2 using only command line 
options. MAKER2 therefore uses a set of three default configuration files to setup 
options for genome annotation, these files are: maker_opts.ctl (contains parameters 
most likely to be configured by the user, i.e., the location of the all input FASTA and 
GFF3 files), maker_bopts.ctl (contains filtering statistics for the programs BLAST[2] 
and Exonerate[3] which MAKER2 uses to process evidence alignments), and 
maker_exe.ctl (contains the path information to prerequisite executables that 
MAKER2 uses to analyze input datasets). The annotation configuration files are 
run-specific meaning they must be generated and configured anew for each genome 




The output format for MAKER2 produced genome annotations is GFF3; 
additionally, protein and transcript sequence from final gene models is produced in 
FASTA format (which is the de facto standard for sequence data used throughout 
biology). GFF3 is the file format commonly used by the Generic Model Organism 
Database project (GMOD)[4]. By using GFF3, MAKER2’s output becomes 
automatically compatible with the extensive library of GMOD tools already available 
for easy downstream analysis of genome annotations. 
Step-by-step overview of MAKER2 
As a software pipeline, MAKER2 leverages the capabilities of many external 
tools, and integrates their output to produce final results. Because of the large 
number of steps and interactions involved I have a created a flowchart (Figure 6.1) 
to help assist in my explanation of how exactly the MAKER2 algorithm is designed 
to work. 
Dataset initialization in MAKER2 
When MAKER2 starts, it searches for and loads the three default annotation 
control files I described earlier (maker_opts.ctl, maker_bopts.ctl, and maker_exe.ctl). 
From these files MAKER2 extracts the location of any input datasets for the 
pipeline. FASTA format files that are supplied to MAKER2 are parsed for errors and 
then divided into smaller datasets (each file is split into 10 smaller files). Splitting 
the files this way allows for faster indexing and rapid access to entries within the 
file. Having large files split into smaller datasets also permits MAKER2 to improve 
performance as each small dataset can be distributed to a separate CPU and 
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processed in parallel. For GFF3 format files, MAKER2 checks the entries for errors 
and loads them into an SQLite database. This is done because these datasets contain 
pre-aligned features, so they do not need to be processed and aligned the way 
FASTA files do. MAKER2 only requires rapid indexed access to the entries in the 
GFF3 file, and this is achieved via the database. 
Parallelization of MAKER2 
MAKER2 supports parallelization via Message Passing Interface (MPI), a 
distributed communication protocol. As opposed to other parallelization method MPI 
has the advantage of splitting threads between systems, meaning the same program 
can run on multiple computers (treating them all as if they were a single powerful 
machine). While MPI compatible programs can be installed and run on laptop and 
desktop machines, there are systems that are specially optimized for this 
mechanism of parallelization. These systems are referred to as computer clusters, 
and they can contain thousands of CPUs on hundreds of interconnect computers 
working in tandem. 
While parallelization via MPI does greatly expand the number of CPUs 
available for computation, it also introduces many design constraints. Because two 
threads of the same program might not be running on the same computer, it cannot 
be assumed that they will have access to each other’s memory or even each other’s 
hard drives. Every effort must therefore be made to divide computation into small 
jobs that can be fully self-contained (i.e., each thread will not need to know the 
results of another thread). These small jobs can then run from start to finish while 
minimizing the need for communication and coordination between threads. 
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Once initialized, MAKER2 begins to divide datasets among CPUs depending 
on the number of processors indicated by the user. MAKER2 uses a host/client 
hierarchy for distributing data. Under this model one thread is dedicated to 
receiving and answering requests (the host) while all other threads take instructions 
and ask for datasets to work with from the host (the clients). MAKER2 at first 
attempts to divide contigs from the input genomic sequence among all CPUs; in this 
way, each CPU can analyze a single contig from start to finish (see Figure 6.1, blue 
parallelization arrows). This allows MAKER2 to avoid, for the most part, any issues 
with synchronizing annotation steps between CPUs. However, when the host thread 
runs out of contigs to distribute, client threads are given the option to break contigs 
currently in their possession into smaller chunks (using genomic sequence). Client 
threads then distribute those sequence chunks to other threads (see Figure 6.1, 
green parallelization arrows). 
These chunks are usually 100,000 base pairs in length (this can be configured 
in the MAKER2 control files). Normally each client thread processes contigs one 
chunk at a time, running all annotation analyses on that sequence region to 
completion and then moving on to the next chunk (this is like walking across the 
contigs in 100,000 base pair steps, and it helps minimize the memory footprint of 
MAKER2). When a client thread has been told by the host that it is ok to distribute 
chunks to other clients, then that thread will walk down the contig distributing 
chunks until there is no more sequence or there are no more clients. Because all 
annotation steps on each chunk are run to completion on the same thread, overhead 




As a MAKER2 annotation job advances to completion, the host and client 
nodes eventually run out of both contigs and sequence chunks for distribution. 
During these final stages of analysis, MAKER2 will attempt to finish annotation by 
moving to a third level of parallelization. Because most of the compute time in 
MAKER2 is spent aligning experimental evidence from ESTs and protein sequence 
via BLAST[2], MAKER2 can divide the BLAST databases among the threads, thus 
splitting up the work (see Figure 6.1, purple parallelization arrows). Distributing 
analyses in this way is facilitated by the fact that FASTA datasets were divided into 
smaller files during MAKER2 initialization. MAKER2 can then just distribute those 
datasets among the different threads. Unlike previous parallelization steps, though, 
MAKER2 now requires synchronization between threads, which will induce a 
performance penalty. However this third level of parallelization is only encountered 
toward the end of whole genome analysis so the resulting total overhead is minimal 
compared to total runtime. As a result MAKER2’s performance scales almost 
linearly without noticeable loss in data throughput as the number of CPUs is 
increased (this can be seen in Chapter 2, Figure 2.6). 
Repeat masking 
The first step to MAKER2 is repeat masking; but why do we need to do this? 
Repetitive elements can make up a significant portion of a eukaryotic genome. Many 
of these elements are simple/low-complexity repeats of C's or G's or even 
dinucleotide repeats. Other repeats are more complex (i.e., transposable elements). 
These high-complexity repeats often encode real proteins like rerotranscriptase or 
even Gag, Pol, and Env viral proteins. Because repeats can encode real proteins, 
they can play havoc with ab initio gene-predictors. For example, a transposable 
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element that occurs next to or even within the intron of a ‘real’ protein-encoding 
gene might cause a gene-predictor to include extra exons as part of a gene model. 
These exons, however, really only belongs to the transposable element and not to the 
coding sequence of the gene. Other repeats may even be annotated as being 
individual genes. Because repeat families can exist in high copy numbers 
(numbering into the thousands), the final count of gene predictions can then be 
inflated by orders of magnitude, thus washing out the signal of the organisms true 
proteome in a flood of nearly identical bad gene calls. 
In addition to issues of false gene prediction, repeats can also induce 
problems of false cross-species homology. Low-complexity repeat regions tend to 
align with certain kinds of experimental evidence such as structural proteins (which 
often have repetitive amino acid sequence to induce proper folding). While the length 
of these alignments can result in high statistical significance, closer analyses reveals 
that the alignment is more likely the result of random expansion of repetitive 
sequence. These types of repetitive sequence therefore create spurious protein and 
EST alignments throughout the genome, which undermines the accuracy of the 
annotation process.  
To avoid these complications, it is convenient to identify and mask all repeat 
elements as the very first step of genome annotation. MAKER2 does this as a two-
part process. First, a program called RepeatMasker[5] is used to identify low-
complexity and high-complexity repeats that match entries in either the RepBase[6] 
repeat library or any species specific repeat library supplied by the user (this is an 
analysis in nucleotide space). Next, MAKER2 uses RepeatRunner[7] to identify 
transposable element and viral proteins from the RepeatRunner protein database. 
Because protein sequences diverge at a slower rate than nucleotide sequence, this 
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step helps pick up the problematic regions of divergent repeats that may have been 
missed by RepeatMasker analysis in nucleotide space.  
Regions identified during repeat analysis are masked out so as not to 
complicate other downstream steps of the annotation process. High-complexity 
repeats are hard-masked, a technique in which nucleotide sequence is replaced with 
the letter N to prohibit any alignments to that region. Low-complexity regions are 
soft-masked, a technique in which nucleotides are made lower case so they can be 
treated as masked under certain situations without losing sequence information[8]. 
The idea of masking out sequence may appear, at first, as if a great deal of 
information is being lost. It is after all true that proteins exist which have integrated 
repeats into their true structure, thus repeat masking will affect one’s ability to 
annotate these proteins. However, such proteins are rare, and the number of gene 
models and homology alignments improved by this step far exceed the few gene 
models that may be negatively impacted. However, if users are concerned about the 
effect that repeat masking will have on gene model sensitivity (i.e., false negatives), 
they have the option to run ab initio gene-predictors on both masked and unmasked 
sequences by setting the ‘unmask’ parameter in the maker_opts.ctl file to 1.  
Ab initio gene prediction 
Following repeat masking, MAKER2 runs ab initio gene-predictors specified 
by the user to produce preliminary gene models. Ab initio gene-predictors produce 
gene predictions based on underlying mathematical models describing patterns of 
intron/exon structure, codon usage, and consensus start signals. Because these 
aspects of gene structure differ from organism to organism, gene-predictors must be 
trained before they can be used on a newly sequence genome. Training requires pre-
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existing gene models, which usually do not exist for newly sequenced organisms, but 
MAKER2 is capable of producing rough gene models using evidence alignments. 
These rough models can then be used for initial training of algorithms like SNAP[9] 
(trained according to its internal documentation). See the section in Chapter 2 on 
‘Gene prediction/annotation in second-generation genomes’ for more explanation of 
issues related to training gene-finders.  
MAKER2 currently supports the following gene-prediction programs: SNAP, 
Augustus[10], GeneMark[11], and FGENESH[12]. However MAKER2 can also 
accept gene-predictions produced by other programs if they are supplied in GFF3 
format to the pred_gff options of the maker_opts.ctl file.  
EST and protein evidence alignment 
A simple way to indicate if a sequence region contains a gene is to identify (A) 
if the region is actively being transcribed or (B) if the region has homology to a 
known protein. This can be done by aligning Expressed Sequence Tags (ESTs) and 
proteins to the genome using alignment algorithms like BLAST.  
ESTs are sequences derived from a cDNA library. Because of the difficulties 
associated with working with mRNA and depending on how the cDNA library was 
prepared, EST databases usually represent bits and pieces of transcribed mRNAs 
(with only a few full length transcripts). MAKER2 aligns these sequences to the 
genome using BLASTN. If ESTs from the organism being annotated are unavailable 
or sparse, then ESTs from a closely related organism can be used. However, ESTs 
from closely related organisms are unlikely to align using BLASTN since nucleotide 
sequences can diverge quite rapidly. For these divergent ESTs, MAKER2 uses 
TBLASTX to align them in protein space. Protein sequence generally diverges quite 
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slowly and over large evolutionary distances; as a result, proteins from even 
evolutionarily distant organisms can often be used to identify regions of homology. 
MAKER2 uses BLASTX to align protein datasets. 
As stated previously evidence is being aligned against the repeat-masked 
genomic sequence (remember repeat masking was the first step of the analysis to 
avoid spurious false positive alignments). One of the effects of masking is that 
sequences will not be able to align against low-complexity regions. Unfortunately 
some real proteins do contain low-complexity regions (and they are not all that 
uncommon). It would be beneficial if there were a way to identify regions of true low-
complexity homology without opening up the entire genome to spurious alignments. 
Fortunately the program BLAST provides just such a mechanism. Soft-masking is 
the use of lower case letters to identify a region as masked without losing the 
sequence information. BLAST can restrict any alignments from being seeded in 
these soft masked regions, thus avoiding spurious hits in the BLAST report. But at 
the same time, BLAST can allow alignments that have already reached statistical 
significance outside the masked region to extend through them. This means proteins 
with true homology can align using nonrepetitive conserved domains within their 
structure and then capture true repetitive regions through extension. Proteins 
without true homology, though, should not align because the only regions of 
similarity are the repetitive regions. There will be no conserved region to seed an 
initial alignment, and extension is thus impossible. Setting ‘softmask’ to 0 in the 
maker_opts.ctl file, however, can turn off this behavior.  
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Polishing evidence alignments 
Because of oddities associated with how BLAST statistics work, BLAST 
alignments are not as informative as they could be. BLAST tries to align sequence 
anywhere it can, in every way it can (i.e., reversing the strand, changing the 
alignment order, aligning in fragments, or allowing large gaps). This can become 
especially confusing for genes with repeated domains (they will align to multiple 
places and multiple times), or genes with neighboring paralogous duplications 
(alignments will bridge duplications every way imaginable even splicing together 
unrelated exons from separate genes). To get more informative alignments, 
MAKER2 uses the program Exonerate[3] to polish BLAST hits. MAKER2 uses 
Exonerate to realign each sequence identified by BLAST around splice sites and 
forces the alignments to occur in order. The result is a high quality alignment that 
can be used to suggest near exact intron/exon positions. Polished alignments are 
produced using the est2genome and protein2genome options for the program 
Exonerate.  
One of the benefits of polishing EST alignments is the ability to identify the 
proper strand an EST derives from. Because of amplification steps involved in 
building a cDNA library and limitations involved in some high-throughput 
sequencing technologies, there is no way of telling which strand a sequenced EST 
belongs to. However, if canonical splice sites are taken into account, the EST can 
only align to one strand correctly. 
Integrating evidence to synthesize annotations 
Once MAKER2 has gather evidence from ab initio gene predictions, EST 
alignments, and protein homology, the combined results can be integrated and 
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evaluated to produce even better gene models. MAKER2 does this by ‘talking’ to 
gene-prediction programs like SNAP, Augustus, and FGENESH and providing them 
‘hints’ as to the most probable locations of introns, exons, splice sites, and coding 
regions. The evidence-based ‘hints’ are provided in parameter files that are accepted 
by these algorithms.  
Selecting and revising the final gene model 
MAKER2 next takes the entire pool of ab initio and evidence informed gene-
predictions that correspond to a given locus, and updates them with features such as 
five and three prime UTRs based on EST evidence overlap. The pipeline then tries to 
determine alternative splice forms where EST data permits (i.e., using long ESTs 
with mutually exclusive intron/exon patterns). Finally MAKER2 chooses from 
among all the gene model possibilities the one that best matches the evidence. This 
is done using the modified sensitivity/specificity distance metric AED[13] from the 
Sequence Ontology (also see ‘Calculating Annotation Edit Distance’ in the Methods 
section of Chapter 2). The gene with the lowest AED score is the best match to the 
evidence. 
Quality control statistics 
AED is calculated using the standard sensitivity (SN) and specificity (SP) 
equations[14] with the only difference being that the reference is the aligned 
experimental evidence rather than a high quality gene model. When calculating 
AED, the base pair level sensitivity equation is SN = |i∩j|/|j|; where |i∩j| 
represents the number of overlapping nucleotides between a gene prediction i and 
the aligned evidence j, and |j| represents the total number of nucleotides in the 
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evidence. Specificity is calculated using the equation SP = |i∩j|/|i|. The average of 
sensitivity and specificity is congruency; where C = (SN+SP)/2. AED represents the 
incongruency, or distance between i and j, using the equation AED = 1-C. An AED 
value of 0 indicates no distance between the evidence and an annotation, so the 
annotation is in perfect agreement with aligned evidence. In contrast a value of 1 
means no evidence support. 
In addition to AED, MAKER2 also calculates other metrics that summarize 
how different evidence types support gene annotations. These are MAKER2’s 
Quality Indices (QI) and are reported for each gene as part of the GFF3 output. 
Statistics calculated for the Quality Indices are shown in Figure 6.2. These metrics 
are invaluable resource and assist in future downstream management and curation 
of gene models. 
Algorithm stability and error handling 
Because MAKER2 is expected to operate on large, genome-wide datasets, 
computation times can range from several hours to several days. With such long run 
times, issues unrelated to the algorithm itself can arise (i.e., power failures, user 
error, etc.). Stability of the program is therefore a critical issue. MAKER2 uses log 
files to automatically register the progress of each analysis MAKER2 performs. In 
this way, the program can restart where it left off without unnecessary reprocessing 
of existing data. Also, when there is a failure processing any of the contigs from the 
genome input file, MAKER2 skips to the next contig and continues processing. 
Failed contigs are then retried at the end of the whole-genome analysis, and any 
contigs that fail multiple times are separated into external files for user review. The 
robustness of this mechanism allows a researcher to start MAKER2 and walk away 
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with little time spent monitoring the status of the compute. The log files produced by 
MAKER2 as part of its normal operation also serve as indicators of what analyses 
should be re-run or maintained if a user decides to restart annotation using different 
parameters. MAKER2 is, thus, highly efficient and avoids redoing any analyses 
unnecessarily. 
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Figure 6.2 Summary of MAKER2’s Quality Indices. 
MAKER2’s Quality Indices provide basic summary statistics for how well gene 



























SUMMARY AND CONCLUSIONS 
MAKER2 is seeing widespread adoption by the scientific community. There 
are over 700 research projects around the world actively using MAKER2 (registered 
on Yandell-lab.org), and already over a dozen published genomics manuscripts have 
listed MAKER2 as an integral tool in their analyses[1-13]. There will undoubtedly 
continue to be a need for MAKER2 as sequencing costs continue to fall, thus making 
it possible for even individual labs to sequence and annotate entire genomes. 
In the course of my thesis work, I have had the opportunity to develop new 
techniques and methods in order to solve the annotation challenges presented by the 
different genomes I have worked with and annotated. This has produced the robust 
and powerful pipeline that MAKER2 has become today. My many annotation 
collaborations have contributed critically to the biological understanding of multiple 
new model organisms, and the annotation databases I have helped to create are 
currently informing downstream experimental work in hundreds of laboratories 
around the world. 
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